| Year |
Citation |
Score |
| 2024 |
Hoxie I, Vasilev K, Clark JJ, Bushfield K, Francis B, Loganathan M, Campbell JD, Yu D, Guan L, Gu C, Fan S, Tompkins SM, Neumann G, Kawaoka Y, Krammer F. A recombinant N2 neuraminidase-based CpG 1018® adjuvanted vaccine provides protection against challenge with heterologous influenza viruses in mice and hamsters. Vaccine. 42: 126269. PMID 39241354 DOI: 10.1016/j.vaccine.2024.126269 |
0.486 |
|
| 2024 |
Neumann G, Kawaoka Y. Highly pathogenic H5N1 avian influenza virus outbreak in cattle: the knowns and unknowns. Nature Reviews. Microbiology. PMID 39060613 DOI: 10.1038/s41579-024-01087-1 |
0.623 |
|
| 2024 |
Eiden J, Fierro C, White A, Davis M, Rhee M, Turner M, Murray B, Herber R, Aitchison R, Marshall D, Moser MJ, Belshe R, Greenberg H, Coelingh K, Kawaoka Y, et al. Safety and immunogenicity of the intranasal H3N2 M2-deficient single-replication influenza vaccine alone or coadministered with an inactivated influenza vaccine (Fluzone High-Dose Quadrivalent) in adults aged 65-85 years in the USA: a multicentre, randomised, double-blind, double-dummy, phase 1b trial. The Lancet. Infectious Diseases. PMID 39004096 DOI: 10.1016/S1473-3099(24)00351-7 |
0.397 |
|
| 2024 |
Eisfeld AJ, Biswas A, Guan L, Gu C, Maemura T, Trifkovic S, Wang T, Babujee L, Dahn R, Halfmann PJ, Barnhardt T, Neumann G, Suzuki Y, Thompson A, Swinford AK, ... ... Kawaoka Y, et al. Pathogenicity and transmissibility of bovine H5N1 influenza virus. Nature. PMID 38977017 DOI: 10.1038/s41586-024-07766-6 |
0.632 |
|
| 2024 |
Takashita E, Ichikawa M, Fujisaki S, Morita H, Nagata S, Miura H, Watanabe S, Hasegawa H, Kawaoka Y. Antiviral susceptibility of SARS-CoV-2 and influenza viruses from 3 co-infected pediatric patients. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. 107134. PMID 38944411 DOI: 10.1016/j.ijid.2024.107134 |
0.586 |
|
| 2024 |
Shimizu K, Kawakami C, Matsuzaki Y, Fujisaki S, Nagata S, Morita H, Watanabe K, Miura H, Momoki T, Saikusa M, Ozawa H, Kumazaki M, Usuku S, Tanaka N, Senda R, ... ... Kawaoka Y, et al. Monitoring Influenza C and D Viruses in Patients With Respiratory Diseases in Japan, January 2018 to March 2023. Influenza and Other Respiratory Viruses. 18: e13345. PMID 38923307 DOI: 10.1111/irv.13345 |
0.553 |
|
| 2024 |
Guan L, Eisfeld AJ, Pattinson D, Gu C, Biswas A, Maemura T, Trifkovic S, Babujee L, Presler R, Dahn R, Halfmann PJ, Barnhardt T, Neumann G, Thompson A, Swinford AK, ... ... Kawaoka Y, et al. Cow's Milk Containing Avian Influenza A(H5N1) Virus - Heat Inactivation and Infectivity in Mice. The New England Journal of Medicine. PMID 38785313 DOI: 10.1056/NEJMc2405495 |
0.524 |
|
| 2024 |
Guan L, Babujee L, Presler R, Pattinson D, Nguyen HLK, Hoang VMP, Le MQ, Bakel HV, Kawaoka Y, Neumann G. Avian H6 Influenza Viruses in Vietnamese Live Bird Markets during 2018-2021. Viruses. 16. PMID 38543733 DOI: 10.3390/v16030367 |
0.569 |
|
| 2024 |
Hill-Batorski L, Bowen R, Bielefeldt-Ohmann H, Moser MJ, Matejka SM, Marshall D, Kawaoka Y, Neumann G, Bilsel P. Mucosal immunization with dual influenza/COVID-19 single-replication virus vector protects hamsters from SARS-CoV-2 challenge. Vaccine. PMID 38508930 DOI: 10.1016/j.vaccine.2024.03.040 |
0.522 |
|
| 2024 |
Gu C, Fan S, Dahn R, Babujee L, Chiba S, Guan L, Maemura T, Pattinson D, Neumann G, Kawaoka Y. Characterization of a human H3N8 influenza virus. Ebiomedicine. 101: 105034. PMID 38408394 DOI: 10.1016/j.ebiom.2024.105034 |
0.601 |
|
| 2024 |
Fan S, Kong H, Babujee L, Presler R, Jester P, Burke D, Pattinson D, Barr I, Smith D, Neumann G, Kawaoka Y. Assessment of the antigenic evolution of a clade 6B.1 human H1N1pdm influenza virus revealed differences between ferret and human convalescent sera. Ebiomedicine. 101: 105013. PMID 38364702 DOI: 10.1016/j.ebiom.2024.105013 |
0.568 |
|
| 2024 |
Halfmann PJ, Loeffler K, Duffy A, Kuroda M, Yang JE, Wright ER, Kawaoka Y, Kane RS. Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccine. Nature Communications. 15: 1284. PMID 38346966 DOI: 10.1038/s41467-024-45495-6 |
0.338 |
|
| 2024 |
Hagihara M, Hayashi H, Nakashima S, Imai Y, Nakano H, Uchida T, Inoue M, Sakai-Tagawa Y, Ito M, Yamayoshi S, Iwatsuki-Horimoto K, Suzuki Y, Kawaoka Y. Clinical Efficacy of Imdevimab/Casirivimab for Persistent Omicron SARS-CoV-2 Infection in Patients with Hematological Malignancies. Internal Medicine (Tokyo, Japan). PMID 38171874 DOI: 10.2169/internalmedicine.2900-23 |
0.301 |
|
| 2023 |
Uraki R, Kiso M, Iwatsuki-Horimoto K, Yamayoshi S, Ito M, Chiba S, Sakai-Tagawa Y, Imai M, Kashima Y, Koga M, Fuwa N, Okumura N, Hojo M, Iwamoto N, Kato H, ... ... Kawaoka Y, et al. Characterization of a SARS-CoV-2 EG.5.1 clinical isolate in vitro and in vivo. Cell Reports. 42: 113580. PMID 38103202 DOI: 10.1016/j.celrep.2023.113580 |
0.37 |
|
| 2023 |
Uraki R, Ito M, Kiso M, Yamayoshi S, Iwatsuki-Horimoto K, Sakai-Tagawa Y, Imai M, Koga M, Yamamoto S, Adachi E, Saito M, Tsutsumi T, Otani A, Fukushi S, Watanabe S, ... ... Kawaoka Y, et al. Antiviral efficacy against and replicative fitness of an XBB.1.9.1 clinical isolate. Iscience. 26: 108147. PMID 37876803 DOI: 10.1016/j.isci.2023.108147 |
0.304 |
|
| 2023 |
Maemura T, Guan L, Gu C, Eisfeld A, Biswas A, Halfmann P, Neumann G, Kawaoka Y. Characterization of highly pathogenic clade 2.3.4.4b H5N1 mink influenza viruses. Ebiomedicine. 97: 104827. PMID 37812908 DOI: 10.1016/j.ebiom.2023.104827 |
0.54 |
|
| 2023 |
Kikuchi C, Antonopoulos A, Wang S, Maemura T, Karamanska R, Lee C, Thompson AJ, Dell A, Kawaoka Y, Haslam SM, Paulson JC. Glyco-engineered MDCK cells display preferred receptors of H3N2 influenza absent in eggs used for vaccines. Nature Communications. 14: 6178. PMID 37794004 DOI: 10.1038/s41467-023-41908-0 |
0.502 |
|
| 2023 |
Chiba S, Halfmann PJ, Iida S, Hirata Y, Sato Y, Kuroda M, Armbrust T, Spyra S, Suzuki T, Kawaoka Y. Recombinant spike protein vaccines coupled with adjuvants that have different modes of action induce protective immunity against SARS-CoV-2. Vaccine. PMID 37635002 DOI: 10.1016/j.vaccine.2023.08.054 |
0.369 |
|
| 2023 |
Guan L, Ping J, Lopes TJS, Fan S, Presler R, Neumann G, Kawaoka Y. Development of an Enhanced High-Yield Influenza Vaccine Backbone in Embryonated Chicken Eggs. Vaccines. 11. PMID 37631932 DOI: 10.3390/vaccines11081364 |
0.554 |
|
| 2023 |
Kuroda M, Halfmann PJ, Thackray LB, Diamond MS, Feldmann H, Marzi A, Kawaoka Y. An antiviral role for TRIM14 in Ebola virus infection. The Journal of Infectious Diseases. PMID 37562033 DOI: 10.1093/infdis/jiad325 |
0.433 |
|
| 2023 |
Guan L, Babujee L, Browning VL, Presler R, Pattinson D, Nguyen HLK, Hoang VMP, Le MQ, van Bakel H, Neumann G, Kawaoka Y. Continued Circulation of Highly Pathogenic H5 Influenza Viruses in Vietnamese Live Bird Markets in 2018-2021. Viruses. 15. PMID 37515281 DOI: 10.3390/v15071596 |
0.573 |
|
| 2023 |
Chiba S, Kong H, Neumann G, Kawaoka Y. Influenza H3 hemagglutinin vaccine with scrambled immunodominant epitopes elicits antibodies directed toward immunosubdominant head epitopes. Mbio. e0062223. PMID 37466314 DOI: 10.1128/mbio.00622-23 |
0.348 |
|
| 2023 |
Kane R, Halfmann P, Loeffler K, Duffy A, Kuroda M, Kawaoka Y. Broad Protection Against Clade 1 Sarbecoviruses After a Single Immunization with Cocktail Spike-Protein-Nanoparticle Vaccine. Research Square. PMID 37461652 DOI: 10.21203/rs.3.rs-3088907/v1 |
0.331 |
|
| 2023 |
Kiso M, Yamayoshi S, Iida S, Furusawa Y, Hirata Y, Uraki R, Imai M, Suzuki T, Kawaoka Y. In vitro and in vivo characterization of SARS-CoV-2 resistance to ensitrelvir. Nature Communications. 14: 4231. PMID 37454219 DOI: 10.1038/s41467-023-40018-1 |
0.468 |
|
| 2023 |
Kiso M, Furusawa Y, Uraki R, Imai M, Yamayoshi S, Kawaoka Y. In vitro and in vivo characterization of SARS-CoV-2 strains resistant to nirmatrelvir. Nature Communications. 14: 3952. PMID 37402789 DOI: 10.1038/s41467-023-39704-x |
0.449 |
|
| 2023 |
Halfmann PJ, Borisevich V, Levine CB, Mire CE, Fenton KA, Geisbert TW, Kawaoka Y, Cross RW. The Mucin-like Domain of the Ebola Glycoprotein Does Not Impact Virulence or Pathogenicity in Ferrets. The Journal of Infectious Diseases. PMID 37379580 DOI: 10.1093/infdis/jiad240 |
0.441 |
|
| 2023 |
Moser MJ, Hill-Batorski L, Bowen RA, Matejka SM, Marshall D, Kawaoka Y, Neumann G, Bilsel P. Intranasal Single-Replication Influenza Vector Induces Cross-Reactive Serum and Mucosal Antibodies against SARS-CoV-2 Variants. Vaccines. 11. PMID 37376452 DOI: 10.3390/vaccines11061063 |
0.446 |
|
| 2023 |
Guan L, Zhong G, Fan S, Plisch EM, Presler R, Gu C, Babujee L, Pattinson D, Le Khanh Nguyen H, Hoang VMP, Le MQ, van Bakel H, Neumann G, Kawaoka Y. Highly Pathogenic H5 Influenza Viruses Isolated between 2016 and 2017 in Vietnamese Live Bird Markets. Viruses. 15. PMID 37243179 DOI: 10.3390/v15051093 |
0.531 |
|
| 2023 |
Kiso M, Yamayoshi S, Kawaoka Y. Efficacy of favipiravir against influenza virus resistant to both baloxavir and neuraminidase inhibitors. The Journal of Antimicrobial Chemotherapy. PMID 37209424 DOI: 10.1093/jac/dkad145 |
0.379 |
|
| 2023 |
Hill-Batorski L, Hatta Y, Moser MJ, Sarawar S, Neumann G, Kawaoka Y, Bilsel P. Quadrivalent Formulation of Intranasal Influenza Vaccine M2SR (M2-Deficient Single Replication) Protects against Drifted Influenza A and B Virus Challenge. Vaccines. 11. PMID 37112710 DOI: 10.3390/vaccines11040798 |
0.414 |
|
| 2023 |
Kawaoka Y. Addressing the Threat of Emerging Viral Infections. The Keio Journal of Medicine. 72: 27. PMID 36967128 DOI: 10.2302/kjm.ABSTRACT_72_1-2 |
0.603 |
|
| 2023 |
Soga T, Duong C, Pattinson D, Sakai-Tagawa Y, Tokita A, Izumida N, Nishino T, Hagiwara H, Wada N, Miyamoto Y, Kuroki H, Hayashi Y, Seki M, Kasuya N, Koga M, ... ... Kawaoka Y, et al. Characterization of Influenza A(H1N1)pdm09 Viruses Isolated in the 2018-2019 and 2019-2020 Influenza Seasons in Japan. Viruses. 15. PMID 36851749 DOI: 10.3390/v15020535 |
0.603 |
|
| 2023 |
Neumann G, Kawaoka Y. The COVID-19 Pandemic-A Potential Role for Antivirals in Mitigating Pandemics. Viruses. 15. PMID 36851516 DOI: 10.3390/v15020303 |
0.353 |
|
| 2023 |
McLean HQ, Petrie JG, Hanson KE, Meece JK, Rolfes MA, Sylvester GC, Neumann G, Kawaoka Y, Belongia EA. Interim Estimates of 2022-23 Seasonal Influenza Vaccine Effectiveness - Wisconsin, October 2022-February 2023. Mmwr. Morbidity and Mortality Weekly Report. 72: 201-205. PMID 36821715 DOI: 10.15585/mmwr.mm7208a1 |
0.522 |
|
| 2023 |
Braun KM, Haddock Iii LA, Crooks CM, Barry GL, Lalli J, Neumann G, Watanabe T, Imai M, Yamayoshi S, Ito M, Moncla LH, Koelle K, Kawaoka Y, Friedrich TC. Avian H7N9 influenza viruses are evolutionarily constrained by stochastic processes during replication and transmission in mammals. Virus Evolution. 9: vead004. PMID 36814938 DOI: 10.1093/ve/vead004 |
0.585 |
|
| 2023 |
Saitoh H, Sakai-Tagawa Y, Nagasawa S, Torimitsu S, Kubota K, Hirata Y, Iwatsuki-Horimoto K, Motomura A, Ishii N, Okaba K, Horioka K, Abe H, Ikemura M, Rokutan H, Hinata M, ... ... Kawaoka Y, et al. High titers of infectious SARS-CoV-2 in COVID-19 corpses. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. PMID 36754229 DOI: 10.1016/j.ijid.2023.01.046 |
0.322 |
|
| 2023 |
Neumann G, Kawaoka Y. Which Virus Will Cause the Next Pandemic? Viruses. 15. PMID 36680238 DOI: 10.3390/v15010199 |
0.468 |
|
| 2022 |
Takashita E, Watanabe S, Hasegawa H, Kawaoka Y. Are twindemics occurring? Influenza and Other Respiratory Viruses. 17: e13090. PMID 36567444 DOI: 10.1111/irv.13090 |
0.457 |
|
| 2022 |
Sarawar S, Gabaglia CR, Sanchez A, Hatta Y, Dias P, Neumann G, Kawaoka Y, Bilsel P. Longevity and Mechanism of Heterosubtypic Protection Induced by M2SR (M2-Deficient Single-Replication) Live Influenza Virus Vaccine in Mice. Vaccines. 10. PMID 36560540 DOI: 10.3390/vaccines10122131 |
0.445 |
|
| 2022 |
Chiba S, Hatta M, Pattinson D, Yasuhara A, Neumann G, Kawaoka Y. Ferret model to mimic the sequential exposure of humans to historical H3N2 influenza viruses. Vaccine. PMID 36517323 DOI: 10.1016/j.vaccine.2022.12.005 |
0.528 |
|
| 2022 |
Boon ACM, Darling TL, Halfmann PJ, Franks J, Webby RJ, Barouch DH, Port JR, Munster VJ, Diamond MS, Kawaoka Y. Reduced airborne transmission of SARS-CoV-2 BA.1 Omicron virus in Syrian hamsters. Plos Pathogens. 18: e1010970. PMID 36459536 DOI: 10.1371/journal.ppat.1010970 |
0.52 |
|
| 2022 |
Eiden J, Fierro C, Schwartz H, Adams M, Ellis KJ, Aitchison R, Herber R, Hatta Y, Marshall D, Moser MJ, Belshe R, Greenberg H, Coelingh K, Kawaoka Y, Neumann G, et al. Intranasal M2SR (M2-deficient Single Replication) H3N2 Influenza Vaccine Provides Enhanced Mucosal and Serum Antibodies In Adults. The Journal of Infectious Diseases. PMID 36350017 DOI: 10.1093/infdis/jiac433 |
0.407 |
|
| 2022 |
Yasuhara A, Yamayoshi S, Kiso M, Sakai-Tagawa Y, Okuda M, Kawaoka Y. A broadly protective human monoclonal antibody targeting the sialidase activity of influenza A and B virus neuraminidases. Nature Communications. 13: 6602. PMID 36329075 DOI: 10.1038/s41467-022-34521-0 |
0.53 |
|
| 2022 |
Imai M, Takada K, Kawaoka Y. Receptor-Binding Specificity of Influenza Viruses. Methods in Molecular Biology (Clifton, N.J.). 2556: 79-96. PMID 36175629 DOI: 10.1007/978-1-0716-2635-1_8 |
0.601 |
|
| 2022 |
Ohta M, Kambayashi Y, Mita H, Kuroda T, Bannai H, Tsujimura K, Yamanaka T, Garvey M, Cullinane A, Yamayoshi S, Kawaoka Y, Nemoto M. Protective efficacy of a reverse genetics-derived inactivated vaccine against equine influenza virus in horses. Vaccine. PMID 36175213 DOI: 10.1016/j.vaccine.2022.09.047 |
0.453 |
|
| 2022 |
Meng F, Yang H, Qu Z, Chen Y, Zhang Y, Zhang Y, Liu L, Zeng X, Li C, Kawaoka Y, Chen H. A Eurasian avian-like H1N1 swine influenza reassortant virus became pathogenic and highly transmissible due to mutations in its PA gene. Proceedings of the National Academy of Sciences of the United States of America. 119: e2203919119. PMID 35969783 DOI: 10.1073/pnas.2203919119 |
0.615 |
|
| 2022 |
Fan S, Gu C, Kong H, Guan L, Neumann G, Kawaoka Y. Influenza Viruses Suitable for Studies in Syrian Hamsters. Viruses. 14. PMID 35893694 DOI: 10.3390/v14081629 |
0.56 |
|
| 2022 |
Belser JA, Lau EHY, Barclay W, Barr IG, Chen H, Fouchier RAM, Hatta M, Herfst S, Kawaoka Y, Lakdawala SS, Lee LYY, Neumann G, Peiris M, Perez DR, Russell C, et al. Robustness of the Ferret Model for Influenza Risk Assessment Studies: a Cross-Laboratory Exercise. Mbio. e0117422. PMID 35862762 DOI: 10.1128/mbio.01174-22 |
0.461 |
|
| 2022 |
Uraki R, Kiso M, Iida S, Imai M, Takashita E, Kuroda M, Halfmann PJ, Loeber S, Maemura T, Yamayoshi S, Fujisaki S, Wang Z, Ito M, Ujie M, Iwatsuki-Horimoto K, ... ... Kawaoka Y, et al. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2. Nature. PMID 35576972 DOI: 10.1038/s41586-022-04856-1 |
0.335 |
|
| 2022 |
Chong Z, Karl CE, Halfmann PJ, Kawaoka Y, Winkler ES, Keeler SP, Holtzman MJ, Yu J, Diamond MS. Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron. Cell Reports. 39: 110799. PMID 35523172 DOI: 10.1016/j.celrep.2022.110799 |
0.311 |
|
| 2022 |
Okuda M, Sakai-Tagawa Y, Koga M, Koibuchi T, Kikuchi T, Adachi E, Lim LA, Yamamoto S, Yotsuyanagi H, Negishi K, Jubishi D, Yamayoshi S, Kawaoka Y. Immunological correlates of prevention of the onset of seasonal H3N2 influenza. The Journal of Infectious Diseases. PMID 35478039 DOI: 10.1093/infdis/jiac152 |
0.543 |
|
| 2022 |
Murakami J, Shibata A, Neumann G, Imai M, Watanabe T, Kawaoka Y. Characterization of H9N2 Avian Influenza Viruses Isolated from Poultry Products in a Mouse Model. Viruses. 14. PMID 35458458 DOI: 10.3390/v14040728 |
0.614 |
|
| 2022 |
Halfmann PJ, Kuroda M, Maemura T, Chiba S, Armbrust T, Wright R, Balaram A, Florek KR, Bateman AC, Kawaoka Y. Efficacy of vaccination and previous infection against the Omicron BA.1 variant in Syrian hamsters. Cell Reports. 39: 110688. PMID 35421378 DOI: 10.1016/j.celrep.2022.110688 |
0.338 |
|
| 2022 |
Kawaoka Y, Uraki R, Kiso M, Iida S, Imai M, Takashita E, Kuroda M, Halfmann P, Loeber S, Maemura T, Yamayoshi S, Fujisaki S, Wang Z, Ito M, Ujie M, et al. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2. Research Square. PMID 35233565 DOI: 10.21203/rs.3.rs-1375091/v1 |
0.335 |
|
| 2022 |
Neumann G, Kawaoka Y. Seasonality of influenza and other respiratory viruses. Embo Molecular Medicine. e15352. PMID 35157360 DOI: 10.15252/emmm.202115352 |
0.536 |
|
| 2022 |
Halfmann PJ, Kuroda M, Armbrust T, Accola M, Valdez R, Kowalski-Dobson T, Rehrauer W, Gordon A, Kawaoka Y. Long-term, infection-acquired immunity against the SARS-CoV-2 Delta variant in a hamster model. Cell Reports. 38: 110394. PMID 35139368 DOI: 10.1016/j.celrep.2022.110394 |
0.348 |
|
| 2022 |
Yoshimi K, Takeshita K, Yamayoshi S, Shibumura S, Yamauchi Y, Yamamoto M, Yotsuyanagi H, Kawaoka Y, Mashimo T. CRISPR-Cas3-based diagnostics for SARS-CoV-2 and influenza virus. Iscience. 25: 103830. PMID 35128347 DOI: 10.1016/j.isci.2022.103830 |
0.392 |
|
| 2022 |
Chong Z, Karl CE, Halfmann PJ, Kawaoka Y, Winkler ES, Yu J, Diamond MS. Nasally-delivered interferon-λ protects mice against upper and lower respiratory tract infection of SARS-CoV-2 variants including Omicron. Biorxiv : the Preprint Server For Biology. PMID 35118466 DOI: 10.1101/2022.01.21.477296 |
0.303 |
|
| 2022 |
Chiba S, Kiso M, Nakajima N, Iida S, Maemura T, Kuroda M, Sato Y, Ito M, Okuda M, Yamada S, Iwatsuki-Horimoto K, Watanabe T, Imai M, Armbrust T, Baric RS, ... ... Kawaoka Y, et al. Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model. Mbio. e0304421. PMID 35100870 DOI: 10.1128/mbio.03044-21 |
0.403 |
|
| 2022 |
Sugita Y, Matsunami H, Kawaoka Y, Noda T, Wolf M. Author Correction: Cryo-EM structure of the Ebola virus nucleoprotein-RNA complex at 3.6 Å resolution. Nature. PMID 34992296 DOI: 10.1038/s41586-021-04304-6 |
0.308 |
|
| 2022 |
Kong X, Guan L, Shi J, Kong H, Zhang Y, Zeng X, Tian G, Liu L, Li C, Kawaoka Y, Deng G, Chen H. A single-amino-acid mutation at position 225 in hemagglutinin attenuates H5N6 influenza virus in mice. Emerging Microbes & Infections. 10: 2052-2061. PMID 34686117 DOI: 10.1080/22221751.2021.1997340 |
0.57 |
|
| 2021 |
Eiden J, Gordon G, Fierro C, Herber R, Aitchison R, Belshe R, Greenberg H, Hoft D, Hatta Y, Moser MJ, Tary-Lehmann M, Kawaoka Y, Neumann G, Radspinner P, Bilsel P. Safety and Immunogenicity of M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR) in Adults. Vaccines. 9. PMID 34960134 DOI: 10.3390/vaccines9121388 |
0.37 |
|
| 2021 |
Neumann G, Kawaoka Y. Quo Vadis Influenza? China Cdc Weekly. 3: 1046-1048. PMID 34934513 DOI: 10.46234/ccdcw2021.254 |
0.527 |
|
| 2021 |
Halfmann P, Nakajima N, Sato Y, Takahashi K, Accola M, Chibo S, Fan S, Neumann G, Rehrauer W, Suzuki T, Kawaoka Y. SARS-CoV-2 Interference of Influenza Virus Replication in Syrian Hamsters. The Journal of Infectious Diseases. PMID 34875072 DOI: 10.1093/infdis/jiab587 |
0.61 |
|
| 2021 |
Kong H, Fan S, Takada K, Imai M, Neumann G, Kawaoka Y. H3N2 Influenza Viruses with 12- or 16-Amino Acid Deletions in the Receptor-Binding Region of Their Hemagglutinin Protein. Mbio. e0151221. PMID 34872354 DOI: 10.1128/mBio.01512-21 |
0.456 |
|
| 2021 |
Saito A, Irie T, Suzuki R, Maemura T, Nasser H, Uriu K, Kosugi Y, Shirakawa K, Sadamasu K, Kimura I, Ito J, Wu J, Iwatsuki-Horimoto K, Ito M, Yamayoshi S, ... ... Kawaoka Y, et al. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation. Nature. PMID 34823256 DOI: 10.1038/s41586-021-04266-9 |
0.357 |
|
| 2021 |
Ohtsuka J, Imai M, Fukumura M, Maeda M, Eguchi A, Ono R, Maemura T, Ito M, Yamayoshi S, Kataoka Y, Kawaoka Y, Nosaka T. Non-propagative human parainfluenza virus type 2 nasal vaccine robustly protects the upper and lower airways against SARS-CoV-2. Iscience. 103379. PMID 34805782 DOI: 10.1016/j.isci.2021.103379 |
0.375 |
|
| 2021 |
Eiden J, Volckaert B, Rudenko O, Aitchison R, Herber R, Belshe R, Greenberg H, Coelingh K, Marshall D, Kawaoka Y, Neumann G, Bilsel P. Single Replication M2SR Influenza Vaccine Induced Immune Responses Associated with Protection Against Human Challenge with Highly Drifted H3N2 Influenza Strain. The Journal of Infectious Diseases. PMID 34323977 DOI: 10.1093/infdis/jiab374 |
0.449 |
|
| 2021 |
Hatakeyama D, Shoji M, Ogata S, Masuda T, Nakano M, Komatsu T, Saitoh A, Makiyama K, Tsuneishi H, Miyatake A, Takahira M, Nishikawa E, Ohkubo A, Noda T, Kawaoka Y, et al. Acetylation of the influenza A virus polymerase subunit PA in the N-terminal domain positively regulates its endonuclease activity. The Febs Journal. PMID 34270849 DOI: 10.1111/febs.16123 |
0.446 |
|
| 2021 |
Saito M, Itoh Y, Yasui F, Munakata T, Yamane D, Ozawa M, Ito R, Katoh T, Ishigaki H, Nakayama M, Shichinohe S, Yamaji K, Yamamoto N, Ikejiri A, Honda T, ... ... Kawaoka Y, et al. Macrocyclic peptides exhibit antiviral effects against influenza virus HA and prevent pneumonia in animal models. Nature Communications. 12: 2654. PMID 33976181 DOI: 10.1038/s41467-021-22964-w |
0.563 |
|
| 2021 |
Nemoto M, Ohta M, Yamanaka T, Kambayashi Y, Bannai H, Tsujimura K, Yamayoshi S, Kawaoka Y, Cullinane A. Antigenic differences between equine influenza virus vaccine strains and Florida sublineage clade 1 strains isolated in Europe in 2019. Veterinary Journal (London, England : 1997). 272: 105674. PMID 33941332 DOI: 10.1016/j.tvjl.2021.105674 |
0.351 |
|
| 2021 |
Takashita E, Kawakami C, Momoki T, Saikusa M, Shimizu K, Ozawa H, Kumazaki M, Usuku S, Tanaka N, Okubo I, Morita H, Nagata S, Watanabe S, Hasegawa H, Kawaoka Y. Increased risk of rhinovirus infection in children during the coronavirus disease-19 pandemic. Influenza and Other Respiratory Viruses. PMID 33715290 DOI: 10.1111/irv.12854 |
0.463 |
|
| 2021 |
Braun KM, Moreno GK, Halfmann PJ, Hodcroft EB, Baker DA, Boehm EC, Weiler AM, Haj AK, Hatta M, Chiba S, Maemura T, Kawaoka Y, Koelle K, O'Connor DH, Friedrich TC. Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck. Plos Pathogens. 17: e1009373. PMID 33635912 DOI: 10.1371/journal.ppat.1009373 |
0.301 |
|
| 2021 |
Kong H, Burke DF, da Silva Lopes TJ, Takada K, Imai M, Zhong G, Hatta M, Fan S, Chiba S, Smith D, Neumann G, Kawaoka Y. Plasticity of the Influenza Virus H5 HA Protein. Mbio. 12. PMID 33563825 DOI: 10.1128/mBio.03324-20 |
0.467 |
|
| 2021 |
Ohta M, Bannai H, Kambayashi Y, Tamura N, Tsujimura K, Yamayoshi S, Kawaoka Y, Nemoto M. Growth properties and immunogenicity of a virus generated by reverse genetics for an inactivated equine influenza vaccine. Equine Veterinary Journal. 54: 139-144. PMID 33527477 DOI: 10.1111/evj.13431 |
0.401 |
|
| 2021 |
Alzhanova D, Corcoran K, Bailey AG, Long K, Taft-Benz S, Graham RL, Broussard GS, Heise M, Neumann G, Halfmann P, Kawaoka Y, Baric RS, Damania B, Dittmer DP. Novel modulators of p53-signaling encoded by unknown genes of emerging viruses. Plos Pathogens. 17: e1009033. PMID 33411764 DOI: 10.1371/journal.ppat.1009033 |
0.423 |
|
| 2020 |
Yamayoshi S, Kawaoka Y. Emergence of SARS-CoV-2 and its outlook. Global Health & Medicine. 2: 1-2. PMID 33330766 DOI: 10.35772/ghm.2020.01009 |
0.37 |
|
| 2020 |
Yamayoshi S, Sakai-Tagawa Y, Koga M, Akasaka O, Nakachi I, Koh H, Maeda K, Adachi E, Saito M, Nagai H, Ikeuchi K, Ogura T, Baba R, Fujita K, Fukui T, ... ... Kawaoka Y, et al. Comparison of Rapid Antigen Tests for COVID-19. Viruses. 12. PMID 33322035 DOI: 10.3390/v12121420 |
0.346 |
|
| 2020 |
Hou YJ, Chiba S, Halfmann P, Ehre C, Kuroda M, Dinnon KH, Leist SR, Schäfer A, Nakajima N, Takahashi K, Lee RE, Mascenik TM, Graham R, Edwards CE, Tse LV, ... ... Kawaoka Y, et al. SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo. Science (New York, N.Y.). PMID 33184236 DOI: 10.1126/science.abe8499 |
0.433 |
|
| 2020 |
Ueki H, Furusawa Y, Iwatsuki-Horimoto K, Imai M, Kabata H, Nishimura H, Kawaoka Y. Effectiveness of Face Masks in Preventing Airborne Transmission of SARS-CoV-2. Msphere. 5. PMID 33087517 DOI: 10.1128/mSphere.00637-20 |
0.307 |
|
| 2020 |
Hou YJ, Chiba S, Halfmann P, Ehre C, Kuroda M, Dinnon KH, Leist SR, Schäfer A, Nakajima N, Takahashi K, Lee RE, Mascenik TM, Edwards CE, Tse LV, Boucher RC, ... ... Kawaoka Y, et al. SARS-CoV-2 D614G Variant Exhibits Enhanced Replication and Earlier Transmission . Biorxiv : the Preprint Server For Biology. PMID 33024969 DOI: 10.1101/2020.09.28.317685 |
0.49 |
|
| 2020 |
Westmark CJ, Kiso M, Halfmann P, Westmark PR, Kawaoka Y. Repurposing Fragile X Drugs to Inhibit SARS-CoV-2 Viral Reproduction Frontiers in Cell and Developmental Biology. 8. PMID 32984339 DOI: 10.3389/Fcell.2020.00856 |
0.341 |
|
| 2020 |
Imai M, Iwatsuki-Horimoto K, Hatta M, Loeber S, Halfmann PJ, Nakajima N, Watanabe T, Ujie M, Takahashi K, Ito M, Yamada S, Fan S, Chiba S, Kuroda M, Guan L, ... ... Kawaoka Y, et al. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proceedings of the National Academy of Sciences of the United States of America. PMID 32571934 DOI: 10.1073/Pnas.2009799117 |
0.401 |
|
| 2020 |
Yamamoto M, Kiso M, Sakai-Tagawa Y, Iwatsuki-Horimoto K, Imai M, Takeda M, Kinoshita N, Ohmagari N, Gohda J, Semba K, Matsuda Z, Kawaguchi Y, Kawaoka Y, Inoue JI. The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner. Viruses. 12. PMID 32532094 DOI: 10.3390/V12060629 |
0.355 |
|
| 2020 |
Kuroda M, Halfmann PJ, Hill-Batorski L, Ozawa M, Lopes TJS, Neumann G, Schoggins JW, Rice CM, Kawaoka Y. Identification of interferon-stimulated genes that attenuate Ebola virus infection. Nature Communications. 11: 2953. PMID 32528005 DOI: 10.1038/S41467-020-16768-7 |
0.605 |
|
| 2020 |
Fukuyama S, Iwatsuki-Horimoto K, Kiso M, Nakajima N, Gregg RW, Katsura H, Tomita Y, Maemura T, da Silva Lopes TJ, Watanabe T, Shoemaker JE, Hasegawa H, Yamayoshi S, Kawaoka Y. Pathogenesis of influenza A(H7N9) virus in aged non-human primates. The Journal of Infectious Diseases. PMID 32433769 DOI: 10.1093/Infdis/Jiaa267 |
0.56 |
|
| 2020 |
Halfmann PJ, Hatta M, Chiba S, Maemura T, Fan S, Takeda M, Kinoshita N, Hattori SI, Sakai-Tagawa Y, Iwatsuki-Horimoto K, Imai M, Kawaoka Y. Transmission of SARS-CoV-2 in Domestic Cats. The New England Journal of Medicine. PMID 32402157 DOI: 10.1056/Nejmc2013400 |
0.45 |
|
| 2020 |
Feng H, Nakatsu S, Lopes TJDS, Imai M, Yamayoshi S, Yamashita M, Watanabe T, Kawaoka Y. Identification of Novel Adjuvants for Ebola Virus-Like Particle Vaccine. Vaccines. 8. PMID 32397625 DOI: 10.3390/Vaccines8020215 |
0.524 |
|
| 2020 |
Kiso M, Yamayoshi S, Kawaoka Y. Triple combination therapy of favipiravir plus two monoclonal antibodies eradicates influenza virus from nude mice. Communications Biology. 3: 219. PMID 32382088 DOI: 10.1038/s42003-020-0952-y |
0.525 |
|
| 2020 |
Azekawa S, Namkoong H, Mitamura K, Kawaoka Y, Saito F. Co-infection with SARS-CoV-2 and influenza A virus Idcases. 20. PMID 32368495 DOI: 10.1016/J.Idcr.2020.E00775 |
0.549 |
|
| 2020 |
Martinez-Sobrido L, Blanco-Lobo P, Rodriguez L, Fitzgerald T, Zhang H, Nguyen P, Anderson CS, Holden-Wiltse J, Bandyopadhyay S, Nogales A, DeDiego ML, Wasik BR, Miller BL, Henry C, Wilson PC, ... ... Kawaoka Y, et al. Characterizing Emerging Canine H3 Influenza Viruses. Plos Pathogens. 16: e1008409. PMID 32287326 DOI: 10.1371/Journal.Ppat.1008409 |
0.579 |
|
| 2020 |
Neumann G, Kawaoka Y. Optimization of animal models to better predict influenza vaccine efficacy (VA) Vaccine. 38: 2749-2750. PMID 32145878 DOI: 10.1016/J.Vaccine.2020.01.102 |
0.411 |
|
| 2020 |
Yamaji R, Saad MD, Davis CT, Swayne DE, Wang D, Wong FYK, McCauley JW, Peiris JSM, Webby RJ, Fouchier RAM, Kawaoka Y, Zhang W. Pandemic potential of highly pathogenic avian influenza clade 2.3.4.4 A(H5) viruses. Reviews in Medical Virology. e2099. PMID 32135031 DOI: 10.1002/Rmv.2099 |
0.609 |
|
| 2020 |
Maemura T, Fukuyama S, Kawaoka Y. High Levels of miR-483-3p Are Present in Serum Exosomes Upon Infection of Mice With Highly Pathogenic Avian Influenza Virus. Frontiers in Microbiology. 11: 144. PMID 32117163 DOI: 10.3389/Fmicb.2020.00144 |
0.515 |
|
| 2020 |
Watanabe T, Kawaoka Y. Villains or heroes? The raison d'être of viruses. Clinical and Translational Immunology. 9. PMID 32099651 DOI: 10.1002/Cti2.1114 |
0.551 |
|
| 2020 |
Mitake H, Yasuhara A, Lopes TJS, Tagawa-Sakai Y, Shimizu K, Ozawa H, Kawakami C, Morikawa S, Sugaya N, Watanabe T, Kawaoka Y. Comparison of the Pathogenicity in Mice of A(H1N1)pdm09 Viruses Isolated between 2009 and 2015 in Japan. Viruses. 12. PMID 32013144 DOI: 10.3390/V12020155 |
0.657 |
|
| 2020 |
Ueki H, Wang I, Zhao D, Gunzer M, Kawaoka Y. Multicolor two-photon imaging of in vivo cellular pathophysiology upon influenza virus infection using the two-photon IMPRESS. Nature Protocols. 15: 1041-1065. PMID 31996843 DOI: 10.1038/S41596-019-0275-Y |
0.446 |
|
| 2020 |
Kato-Miyashita S, Sakai-Tagawa Y, Yamashita M, Iwatsuki-Horimoto K, Ito M, Tokita A, Hagiwara H, Izumida N, Nishino T, Wada N, Koga M, Adachi E, Jubishi D, Yotsuyanagi H, Kawaoka Y, et al. Antigenic variants of influenza B viruses isolated in Japan during the 2017-2018 and 2018-2019 influenza seasons. Influenza and Other Respiratory Viruses. PMID 31955521 DOI: 10.1111/Irv.12713 |
0.603 |
|
| 2020 |
Furuyama W, Reynolds P, Haddock E, Meade-White K, Quynh Le M, Kawaoka Y, Feldmann H, Marzi A. A single dose of a vesicular stomatitis virus-based influenza vaccine confers rapid protection against H5 viruses from different clades. Npj Vaccines. 5: 4. PMID 31934358 DOI: 10.1038/s41541-019-0155-z |
0.543 |
|
| 2020 |
Li X, Shi J, Guo J, Deng G, Zhang Q, Wang J, He X, Wang K, Chen J, Li Y, Fan J, Kong H, Gu C, Guan Y, Suzuki Y, ... Kawaoka Y, et al. Correction: Genetics, Receptor Binding Property, and Transmissibility in Mammals of Naturally Isolated H9N2 Avian Influenza Viruses. Plos Pathogens. 16: e1008284. PMID 31914139 DOI: 10.1371/journal.ppat.1008284 |
0.441 |
|
| 2020 |
Kiso M, Yamayoshi S, Murakami J, Kawaoka Y. Baloxavir Marboxil Treatment of Nude Mice Infected With Influenza A Virus. The Journal of Infectious Diseases. 221: 1699-1702. PMID 31837268 DOI: 10.1093/Infdis/Jiz665 |
0.572 |
|
| 2019 |
Kuwahara T, Yamayoshi S, Noda T, Kawaoka Y. G Protein Pathway Suppressor 1 Promotes Influenza Virus Polymerase Activity by Activating the NF-κB Signaling Pathway. Mbio. 10. PMID 31848286 DOI: 10.1128/Mbio.02867-19 |
0.604 |
|
| 2019 |
Zhong G, Fan S, Hatta M, Nakatsu S, Walters KB, Lopes TJS, Wang JI, Ozawa M, Karasin A, Li Y, Tong S, Donis RO, Neumann G, Kawaoka Y. Mutations in the NA-like protein of bat influenza H18N11 virus enhance virus replication in mammalian cells, mice, and ferrets. Journal of Virology. PMID 31801857 DOI: 10.1128/Jvi.01416-19 |
0.664 |
|
| 2019 |
Imai M, Yamashita M, Sakai-Tagawa Y, Iwatsuki-Horimoto K, Kiso M, Murakami J, Yasuhara A, Takada K, Ito M, Nakajima N, Takahashi K, Lopes TJS, Dutta J, Khan Z, Kriti D, ... ... Kawaoka Y, et al. Influenza A variants with reduced susceptibility to baloxavir isolated from Japanese patients are fit and transmit through respiratory droplets. Nature Microbiology. PMID 31768027 DOI: 10.1038/S41564-019-0609-0 |
0.568 |
|
| 2019 |
Kiso M, Yamayoshi S, Furusawa Y, Imai M, Kawaoka Y. Treatment of Highly Pathogenic H7N9 Virus-Infected Mice with Baloxavir Marboxil. Viruses. 11: 1066. PMID 31731678 DOI: 10.3390/V11111066 |
0.594 |
|
| 2019 |
Sakai-Tagawa Y, Yamayoshi S, Kawaoka Y. Sensitivity of Commercially Available Influenza Rapid Diagnostic Tests in the 2018-2019 Influenza Season. Frontiers in Microbiology. 10: 2342. PMID 31681207 DOI: 10.3389/Fmicb.2019.02342 |
0.625 |
|
| 2019 |
Matsuzawa Y, Iwatsuki-Horimoto K, Nishimoto Y, Abe Y, Fukuyama S, Hamabata T, Okuda M, Go Y, Watanabe T, Imai M, Arai Y, Fouchier RAM, Yamayoshi S, Kawaoka Y. Antigenic Change in Human Influenza A(H2N2) Viruses Detected by Using Human Plasma from Aged and Younger Adult Individuals. Viruses. 11. PMID 31652870 DOI: 10.3390/V11110978 |
0.618 |
|
| 2019 |
Wu L, Mitake H, Kiso M, Ito M, Iwatsuki-Hirimoto K, Yamayoshi S, Lopes TJS, Feng H, Sumiyoshi R, Shibata A, Osaka H, Imai M, Watanabe T, Kawaoka Y. Characterization of H7N9 avian influenza viruses isolated from duck meat products. Transboundary and Emerging Diseases. PMID 31650680 DOI: 10.1111/Tbed.13398 |
0.677 |
|
| 2019 |
Feldmann F, Kobasa D, Embury-Hyatt C, Grolla A, Taylor T, Kiso M, Kakugawa S, Gren J, Jones SM, Kawaoka Y, Feldmann H. Oseltamivir Is Effective against 1918 Influenza Virus Infection of Macaques but Vulnerable to Escape. Mbio. 10. PMID 31641086 DOI: 10.1128/Mbio.02059-19 |
0.65 |
|
| 2019 |
Feng H, Nakajima N, Wu L, Yamashita M, Lopes TJS, Tsuji M, Hasegawa H, Watanabe T, Kawaoka Y. A Glycolipid Adjuvant, 7DW8-5, Enhances the Protective Immune Response to the Current Split Influenza Vaccine in Mice. Frontiers in Microbiology. 10: 2157. PMID 31620111 DOI: 10.3389/Fmicb.2019.02157 |
0.422 |
|
| 2019 |
Mitchell HD, Eisfeld AJ, Stratton KG, Heller NC, Bramer LM, Wen J, McDermott JE, Gralinski LE, Sims AC, Le MQ, Baric RS, Kawaoka Y, Waters KM. The Role of EGFR in Influenza Pathogenicity: Multiple Network-Based Approaches to Identify a Key Regulator of Non-lethal Infections. Frontiers in Cell and Developmental Biology. 7: 200. PMID 31616667 DOI: 10.3389/Fcell.2019.00200 |
0.604 |
|
| 2019 |
Furusawa Y, Yamada S, da Silva Lopes TJ, Dutta J, Khan Z, Kriti D, van Bakel H, Kawaoka Y. Influenza Virus Polymerase Mutation Stabilizes a Foreign Gene Inserted into the Virus Genome by Enhancing the Transcription/Replication Efficiency of the Modified Segment. Mbio. 10. PMID 31575766 DOI: 10.1128/Mbio.01794-19 |
0.587 |
|
| 2019 |
Feng H, Yamashita M, Wu L, Jose da Silva Lopes T, Watanabe T, Kawaoka Y. Food Additives as Novel Influenza Vaccine Adjuvants. Vaccines. 7. PMID 31554190 DOI: 10.3390/Vaccines7040127 |
0.48 |
|
| 2019 |
Yamada S, Yasuhara A, Kawaoka Y. Soluble Recombinant Hemagglutinin Protein of H1N1pdm09 Influenza Virus Elicits Cross-Protection Against a Lethal H5N1 Challenge in Mice. Frontiers in Microbiology. 10: 2031. PMID 31551968 DOI: 10.3389/Fmicb.2019.02031 |
0.564 |
|
| 2019 |
Mukai Y, Tomita Y, Kryukov K, Nakagawa S, Ozawa M, Matsui T, Tomonaga K, Imanishi T, Kawaoka Y, Watanabe T, Horie M. Identification of a distinct lineage of aviadenovirus from crane feces. Virus Genes. PMID 31549291 DOI: 10.1007/S11262-019-01703-W |
0.522 |
|
| 2019 |
Watanabe T, Suzuki N, Tomonaga K, Sawa H, Matsuura Y, Kawaguchi Y, Takahashi H, Nagasaki K, Kawaoka Y. Neo-virology: The raison d'etre of viruses. Virus Research. 197751. PMID 31520652 DOI: 10.1016/J.Virusres.2019.197751 |
0.541 |
|
| 2019 |
Ujie M, Takada K, Kiso M, Sakai-Tagawa Y, Ito M, Nakamura K, Watanabe S, Imai M, Kawaoka Y. Long-term culture of human lung adenocarcinoma A549 cells enhances the replication of human influenza A viruses. The Journal of General Virology. PMID 31424377 DOI: 10.1099/Jgv.0.001314 |
0.431 |
|
| 2019 |
Arikata M, Itoh Y, Shichinohe S, Nakayama M, Ishigaki H, Kinoshita T, Le MQ, Kawaoka Y, Ogasawara K, Shimizu T. Efficacy of clarithromycin against H5N1 and H7N9 avian influenza a virus infection in cynomolgus monkeys Antiviral Research. 171: 104591. PMID 31421167 DOI: 10.1016/J.Antiviral.2019.104591 |
0.656 |
|
| 2019 |
DiPiazza AT, Fan S, Rattan A, DeDiego ML, Chaves F, Neumann G, Kawaoka Y, Sant AJ. A Novel Vaccine Strategy to Overcome Poor Immunogenicity of Avian Influenza Vaccines through Mobilization of Memory CD4 T Cells Established by Seasonal Influenza. Journal of Immunology (Baltimore, Md. : 1950). PMID 31399519 DOI: 10.4049/Jimmunol.1900819 |
0.451 |
|
| 2019 |
Halfmann PJ, Eisfeld AJ, Watanabe T, Maemura T, Yamashita M, Fukuyama S, Armbrust T, Rozich I, N'jai A, Neumann G, Kawaoka Y, Sahr F. Serological analysis of Ebola virus survivors and close contacts in Sierra Leone: A cross-sectional study. Plos Neglected Tropical Diseases. 13: e0007654. PMID 31369554 DOI: 10.1371/Journal.Pntd.0007654 |
0.529 |
|
| 2019 |
Kingstad-Bakke BA, Chandrasekar SS, Phanse Y, Ross KA, Hatta M, Suresh M, Kawaoka Y, Osorio JE, Narasimhan B, Talaat AM. Effective mosaic-based nanovaccines against avian influenza in poultry. Vaccine. PMID 31300285 DOI: 10.1016/J.Vaccine.2019.06.077 |
0.572 |
|
| 2019 |
Zhong G, Fan S, Lopes TJS, Le MQ, van Bakel H, Dutta J, Smith GJD, Jayakumar J, Nguyen HLK, Hoang PVM, Halfmann P, Hatta M, Su YCF, Neumann G, Kawaoka Y. Isolation of Highly Pathogenic H5N1 Influenza Viruses in 2009-2013 in Vietnam. Frontiers in Microbiology. 10: 1411. PMID 31293548 DOI: 10.3389/Fmicb.2019.01411 |
0.647 |
|
| 2019 |
Moser MJ, Hatta Y, Gabaglia C, Sanchez A, Dias P, Sarawar S, Kawaoka Y, Hatta M, Neumann G, Bilsel P. Single-replication BM2SR vaccine provides sterilizing immunity and cross-lineage influenza B virus protection in mice. Vaccine. PMID 31280945 DOI: 10.1016/J.Vaccine.2019.06.043 |
0.574 |
|
| 2019 |
Nemoto M, Yamayoshi S, Bannai H, Tsujimura K, Kokado H, Kawaoka Y, Yamanaka T. A single amino acid change in hemagglutinin reduces the cross-reactivity of antiserum against an equine influenza vaccine strain. Archives of Virology. 164: 2355-2358. PMID 31227892 DOI: 10.1007/S00705-019-04328-4 |
0.499 |
|
| 2019 |
Liang L, Jiang L, Li J, Zhao Q, Wang J, He X, Huang S, Wang Q, Zhao Y, Wang G, Sun N, Deng G, Shi J, Tian G, Zeng X, ... ... Kawaoka Y, et al. Low Polymerase Activity Attributed to PA Drives the Acquisition of the PB2 E627K Mutation of H7N9 Avian Influenza Virus in Mammals. Mbio. 10. PMID 31213560 DOI: 10.1128/Mbio.01162-19 |
0.587 |
|
| 2019 |
Davis CW, Jackson KJL, McElroy AK, Halfmann P, Huang J, Chennareddy C, Piper AE, Leung Y, Albariño CG, Crozier I, Ellebedy AH, Sidney J, Sette A, Yu T, Nielsen SCA, ... ... Kawaoka Y, et al. Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection. Cell. PMID 31104840 DOI: 10.1016/J.Cell.2019.04.036 |
0.422 |
|
| 2019 |
Takada K, Kawakami C, Fan S, Chiba S, Zhong G, Gu C, Shimizu K, Takasaki S, Sakai-Tagawa Y, Lopes TJS, Dutta J, Khan Z, Kriti D, van Bakel H, Yamada S, ... ... Kawaoka Y, et al. A humanized MDCK cell line for the efficient isolation and propagation of human influenza viruses. Nature Microbiology. PMID 31036910 DOI: 10.1038/S41564-019-0433-6 |
0.614 |
|
| 2019 |
Okuda M, Yamayoshi S, Uraki R, Ito M, Hamabata T, Kawaoka Y. Subclade 2.2.1-Specific Human Monoclonal Antibodies That Recognize an Epitope in Antigenic Site A of Influenza A(H5) Virus HA Detected between 2015 and 2018 Viruses. 11: 321. PMID 30987023 DOI: 10.3390/V11040321 |
0.555 |
|
| 2019 |
Oishi K, Yamayoshi S, Kawaoka Y. Identification of Amino Acid Residues in Influenza A Virus PA-X That Contribute to Enhanced Shutoff Activity. Frontiers in Microbiology. 10: 432. PMID 30894843 DOI: 10.3389/Fmicb.2019.00432 |
0.46 |
|
| 2019 |
Yasuhara A, Yamayoshi S, Kiso M, Sakai-Tagawa Y, Koga M, Adachi E, Kikuchi T, Wang IH, Yamada S, Kawaoka Y. Antigenic drift originating from changes to the lateral surface of the neuraminidase head of influenza A virus. Nature Microbiology. PMID 30886361 DOI: 10.1038/S41564-019-0401-1 |
0.443 |
|
| 2019 |
Kyle JE, Burnum-Johnson KE, Wendler JP, Eisfeld AJ, Halfmann PJ, Watanabe T, Sahr F, Smith RD, Kawaoka Y, Waters KM, Metz TO. Plasma lipidome reveals critical illness and recovery from human Ebola virus disease. Proceedings of the National Academy of Sciences of the United States of America. 116: 3919-3928. PMID 30808769 DOI: 10.1073/Pnas.1815356116 |
0.401 |
|
| 2019 |
Kawakami C, Yamayoshi S, Akimoto M, Nakamura K, Miura H, Fujisaki S, Pattinson DJ, Shimizu K, Ozawa H, Momoki T, Saikusa M, Yasuhara A, Usuku S, Okubo I, Toyozawa T, ... ... Kawaoka Y, et al. Genetic and antigenic characterisation of influenza A(H3N2) viruses isolated in Yokohama during the 2016/17 and 2017/18 influenza seasons. Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin. 24. PMID 30755292 DOI: 10.2807/1560-7917.Es.2019.24.6.1800467 |
0.647 |
|
| 2019 |
Ito M, Yamayoshi S, Murakami K, Saito K, Motojima A, Nakaishi K, Kawaoka Y. Characterization of Mouse Monoclonal Antibodies Against the HA of A(H7N9) Influenza Virus. Viruses. 11: 149. PMID 30754701 DOI: 10.3390/V11020149 |
0.634 |
|
| 2019 |
Yamayoshi S, Kawaoka Y. Host protein mimics viral protein to hinder infection by Ebola virus. Nature. 566: 190-191. PMID 30737499 DOI: 10.1038/D41586-019-00182-1 |
0.519 |
|
| 2019 |
Feng H, Yamashita M, da Silva Lopes TJ, Watanabe T, Kawaoka Y. Injectable Excipients as Novel Influenza Vaccine Adjuvants. Frontiers in Microbiology. 10: 19. PMID 30733711 DOI: 10.3389/Fmicb.2019.00019 |
0.49 |
|
| 2019 |
Williamson L, Flyak AI, Kose N, Bombardi R, Branchizio A, Reddy S, Davidson E, Doranz B, Fusco ML, Saphire EO, Halfmann PJ, Kawaoka Y, Piper AE, Glass PJ, Crowe JE. Early human B cell response to Ebola virus in four U.S. survivors of infection. Journal of Virology. PMID 30728263 DOI: 10.1128/Jvi.01439-18 |
0.467 |
|
| 2019 |
Neumann G, Kawaoka Y. Predicting the Next Influenza Pandemics The Journal of Infectious Diseases. 219. PMID 30715371 DOI: 10.1093/Infdis/Jiz040 |
0.63 |
|
| 2019 |
Tabata KV, Minagawa Y, Kawaguchi Y, Ono M, Moriizumi Y, Yamayoshi S, Fujioka Y, Ohba Y, Kawaoka Y, Noji H. Antibody-free digital influenza virus counting based on neuraminidase activity Scientific Reports. 9: 1067-1067. PMID 30705374 DOI: 10.1038/S41598-018-37994-6 |
0.567 |
|
| 2019 |
Yamayoshi S, Kawaoka Y. Current and future influenza vaccines. Nature Medicine. 25: 212-220. PMID 30692696 DOI: 10.1038/S41591-018-0340-Z |
0.569 |
|
| 2019 |
Nanbo A, Kawaoka Y. Molecular Mechanism of Externalization of Phosphatidylserine on the Surface of Ebola Virus Particles. Dna and Cell Biology. 38: 115-120. PMID 30615471 DOI: 10.1089/Dna.2018.4485 |
0.606 |
|
| 2019 |
Eiden J, Volckaert B, Rudenko O, Ellis R, Aitchison R, Herber R, Belshe R, Greenberg H, Coelingh K, Kawaoka Y, Neumann G, Bilsel P. 2748. Single Intranasal (IN) Dose of M2SR (M2-Deficient Single Replication) Live Influenza Vaccine Protects Adults Against Subsequent Challenge with a Substantially Drifted H3N2 Strain Open Forum Infectious Diseases. 6. DOI: 10.1093/Ofid/Ofz360.2425 |
0.482 |
|
| 2018 |
Eisfeld AJ, Gasper DJ, Suresh M, Kawaoka Y. C57BL/6J and C57BL/6NJ Mice Are Differentially Susceptible to Inflammation-Associated Disease Caused by Influenza A Virus. Frontiers in Microbiology. 9: 3307. PMID 30713529 DOI: 10.3389/Fmicb.2018.03307 |
0.649 |
|
| 2018 |
Ackerman EE, Kawakami E, Katoh M, Watanabe T, Watanabe S, Tomita Y, Lopes TJ, Matsuoka Y, Kitano H, Shoemaker JE, Kawaoka Y. Network-Guided Discovery of Influenza Virus Replication Host Factors. Mbio. 9. PMID 30563907 DOI: 10.1128/Mbio.02002-18 |
0.512 |
|
| 2018 |
Gu C, Zeng X, Song Y, Li Y, Liu L, Kawaoka Y, Zhao D, Chen H. Glycosylation and an amino acid insertion in the head of hemagglutinin independently affect the antigenic properties of H5N1 avian influenza viruses. Science China. Life Sciences. PMID 30515728 DOI: 10.1007/S11427-018-9439-0 |
0.592 |
|
| 2018 |
Yasuhara A, Yamayoshi S, Ito M, Kiso M, Yamada S, Kawaoka Y. Isolation and Characterization of Human Monoclonal Antibodies That Recognize the Influenza A(H1N1)pdm09 Virus Hemagglutinin Receptor-Binding Site and Rarely Yield Escape Mutant Viruses. Frontiers in Microbiology. 9: 2660. PMID 30443246 DOI: 10.3389/Fmicb.2018.02660 |
0.622 |
|
| 2018 |
Bedi S, Noda T, Kawaoka Y, Ono A. A Defect in Influenza A Virus Particle Assembly Specific to Primary Human Macrophages. Mbio. 9. PMID 30352935 DOI: 10.1128/Mbio.01916-18 |
0.514 |
|
| 2018 |
Wu NC, Yamayoshi S, Ito M, Uraki R, Kawaoka Y, Wilson IA. Recurring and Adaptable Binding Motifs in Broadly Neutralizing Antibodies to Influenza Virus Are Encoded on the D3-9 Segment of the Ig Gene. Cell Host & Microbe. 24: 569-578.e4. PMID 30308159 DOI: 10.1016/J.Chom.2018.09.010 |
0.531 |
|
| 2018 |
Yamayoshi S, Yasuhara A, Ito M, Uraki R, Kawaoka Y. Differences in the ease with which mutant viruses escape from human monoclonal antibodies against the HA stem of influenza A virus. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 108: 105-111. PMID 30292135 DOI: 10.1016/J.Jcv.2018.09.016 |
0.627 |
|
| 2018 |
Chiba S, Hill-Batorski L, Neumann G, Kawaoka Y. The Cellular DExD/H-Box RNA Helicase UAP56 Co-localizes With the Influenza A Virus NS1 Protein Frontiers in Microbiology. 9: 2192. PMID 30258431 DOI: 10.3389/Fmicb.2018.02192 |
0.548 |
|
| 2018 |
Hatta M, Zhong G, Chiba S, Lopes TJS, Neumann G, Kawaoka Y. Effectiveness of Whole, Inactivated, Low Pathogenicity Influenza A(H7N9) Vaccine against Antigenically Distinct, Highly Pathogenic H7N9 Virus. Emerging Infectious Diseases. 24: 1910-1913. PMID 30226171 DOI: 10.3201/Eid2410.180403 |
0.618 |
|
| 2018 |
Neumann G, Fan S, Kawaoka Y. Selection of Antigenically Advanced Variants of Influenza Viruses. Methods in Molecular Biology (Clifton, N.J.). 1836: 461-486. PMID 30151587 DOI: 10.1007/978-1-4939-8678-1_22 |
0.665 |
|
| 2018 |
Saphire EO, Schendel SL, Fusco ML, Gangavarapu K, Gunn BM, Wec AZ, Halfmann PJ, Brannan JM, Herbert AS, Qiu X, Wagh K, He S, Giorgi EE, Theiler J, Pommert KBJ, ... ... Kawaoka Y, et al. Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection. Cell. 174: 938-952.e13. PMID 30096313 DOI: 10.1016/J.Cell.2018.07.033 |
0.462 |
|
| 2018 |
Gunn BM, Yu WH, Karim MM, Brannan JM, Herbert AS, Wec AZ, Halfmann PJ, Fusco ML, Schendel SL, Gangavarapu K, Krause T, Qiu X, He S, Das J, Suscovich TJ, ... ... Kawaoka Y, et al. A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus. Cell Host & Microbe. 24: 221-233.e5. PMID 30092199 DOI: 10.1016/J.Chom.2018.07.009 |
0.42 |
|
| 2018 |
Furusawa Y, Yamada S, Kawaoka Y. Host Factor Nucleoporin 93 Is Involved in the Nuclear Export of Influenza Virus RNA. Frontiers in Microbiology. 9: 1675. PMID 30087672 DOI: 10.3389/Fmicb.2018.01675 |
0.614 |
|
| 2018 |
Halfmann P, Hill-Batorski L, Kawaoka Y. The Induction of IL-1β Secretion Through the NLRP3 Inflammasome During Ebola Virus Infection. The Journal of Infectious Diseases. 218. PMID 30060221 DOI: 10.1093/Infdis/Jiy433 |
0.363 |
|
| 2018 |
Oishi K, Yamayoshi S, Kozuka-Hata H, Oyama M, Kawaoka Y. N-Terminal Acetylation by NatB Is Required for the Shutoff Activity of Influenza A Virus PA-X. Cell Reports. 24: 851-860. PMID 30044982 DOI: 10.1016/J.Celrep.2018.06.078 |
0.443 |
|
| 2018 |
Sammaibashi S, Yamayoshi S, Kawaoka Y. Strain-Specific Contribution of Eukaryotic Elongation Factor 1 Gamma to the Translation of Influenza A Virus Proteins. Frontiers in Microbiology. 9: 1446. PMID 30008712 DOI: 10.3389/Fmicb.2018.01446 |
0.615 |
|
| 2018 |
Hatta Y, Boltz D, Sarawar S, Kawaoka Y, Neumann G, Bilsel P. Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunity. Vaccine. 36: 5097-5103. PMID 30007825 DOI: 10.1016/J.Vaccine.2018.06.053 |
0.604 |
|
| 2018 |
Iwatsuki-Horimoto K, Shi J, Wang X, Sakai-Tagawa Y, Ito M, Murakami K, da Silva Lopes TJ, Nakaishi K, Yamayoshi S, Watabe S, Chen H, Kawaoka Y. Development of an Influenza Rapid Diagnostic Kit Specific for the H7 Subtype. Frontiers in Microbiology. 9: 1346. PMID 29988537 DOI: 10.3389/Fmicb.2018.01346 |
0.65 |
|
| 2018 |
Ueki H, Wang I, Fukuyama S, Katsura H, Lopes TJdS, Neumann G, Kawaoka Y. In vivo imaging of the pathophysiological changes and neutrophil dynamics in influenza virus-infected mouse lungs. Proceedings of the National Academy of Sciences of the United States of America. 115: 201806265. PMID 29941581 DOI: 10.1073/Pnas.1806265115 |
0.532 |
|
| 2018 |
Imai H, Dinis JM, Zhong G, Moncla LH, Lopes TJS, McBride R, Thompson AJ, Peng W, Le MTQ, Hanson A, Lauck M, Sakai-Tagawa Y, Yamada S, Eggenberger J, O'Connor DH, ... ... Kawaoka Y, et al. Diversity of Influenza A(H5N1) Viruses in Infected Humans, Northern Vietnam, 2004-2010. Emerging Infectious Diseases. 24: 1128-1238. PMID 29912683 DOI: 10.3201/Eid2407.171441 |
0.652 |
|
| 2018 |
Iwatsuki-Horimoto K, Nakajima N, Kiso M, Takahashi K, Ito M, Inoue T, Horiuchi M, Okahara N, Sasaki E, Hasegawa H, Kawaoka Y. The Marmoset as an Animal Model of Influenza: Infection With A(H1N1)pdm09 and Highly Pathogenic A(H5N1) Viruses via the Conventional or Tracheal Spray Route. Frontiers in Microbiology. 9: 844. PMID 29867791 DOI: 10.3389/Fmicb.2018.00844 |
0.663 |
|
| 2018 |
Kuwahara T, Takashita E, Fujisaki S, Shirakura M, Nakamura K, Kishida N, Takahashi H, Suzuki N, Kawaoka Y, Watanabe S, Odagiri T. Isolation of egg-adapted influenza A(H3N2) virus without amino acid substitutions in the antigenic sites of its hemagglutinin. Japanese Journal of Infectious Diseases. PMID 29709975 DOI: 10.7883/Yoken.Jjid.2017.551 |
0.625 |
|
| 2018 |
Soni P, Yasuhara A, Takenaga T, Iwatsuki-Horimoto K, Uraki R, Ito M, Sasaki T, Ikuta K, Yamayoshi S, Kawaoka Y. Evaluation of the fusion partner cell line SPYMEG for obtaining human monoclonal antibodies against influenza B virus. The Journal of Veterinary Medical Science. PMID 29669959 DOI: 10.1292/Jvms.18-0146 |
0.546 |
|
| 2018 |
Fujihira H, Usami K, Matsuno K, Takeuchi H, Denda-Nagai K, Furukawa J, Shinohara Y, Takada A, Kawaoka Y, Irimura T. A Critical Domain of Ebolavirus Envelope Glycoprotein Determines Glycoform and Infectivity. Scientific Reports. 8: 5495-5495. PMID 29615747 DOI: 10.1038/S41598-018-23357-8 |
0.344 |
|
| 2018 |
Watanabe T, Iwatsuki-Horimoto K, Kiso M, Nakajima N, Takahashi K, Jose da Silva Lopes T, Ito M, Fukuyama S, Hasegawa H, Kawaoka Y. Experimental infection of Cynomolgus Macaques with highly pathogenic H5N1 influenza virus through the aerosol route. Scientific Reports. 8: 4801. PMID 29556081 DOI: 10.1038/S41598-018-23022-0 |
0.62 |
|
| 2018 |
Hatakeyama D, Shoji M, Yamayoshi S, Yoh R, Ohmi N, Takenaka S, Saitoh A, Arakaki Y, Masuda A, Komatsu T, Nagano R, Nakano M, Noda T, Kawaoka Y, Kuzuhara T. Influenza A virus nucleoprotein is acetylated by histone acetyltransferases, PCAF and GCN5. The Journal of Biological Chemistry. PMID 29555684 DOI: 10.1074/Jbc.Ra117.001683 |
0.55 |
|
| 2018 |
Yamayoshi S, Kiso M, Yasuhara A, Ito M, Shu Y, Kawaoka Y. Enhanced Replication of Highly Pathogenic Influenza A(H7N9) Virus in Humans. Emerging Infectious Diseases. 24: 746-750. PMID 29553313 DOI: 10.3201/Eid2404.171509 |
0.656 |
|
| 2018 |
Matsui K, Ozawa M, Kiso M, Yamashita M, Maekawa T, Kubota M, Sugano S, Kawaoka Y. Stimulation of alpha2-adrenergic receptors impairs influenza virus infection. Scientific Reports. 8: 4631. PMID 29545586 DOI: 10.1038/S41598-018-22927-0 |
0.626 |
|
| 2018 |
Maemura T, Fukuyama S, Sugita Y, Lopes TJS, Nakao T, Noda T, Kawaoka Y. Lung-Derived Exosomal miR-483-3p Regulates the Innate Immune Response to Influenza Virus Infection. The Journal of Infectious Diseases. 217: 1372-1382. PMID 29373693 DOI: 10.1093/Infdis/Jiy035 |
0.446 |
|
| 2018 |
Menachery VD, Schäfer A, Burnum-Johnson KE, Mitchell HD, Eisfeld AJ, Walters KB, Nicora CD, Purvine SO, Casey CP, Monroe ME, Weitz KK, Stratton KG, Webb-Robertson BM, Gralinski LE, Metz TO, ... ... Kawaoka Y, et al. MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape. Proceedings of the National Academy of Sciences of the United States of America. PMID 29339515 DOI: 10.1073/Pnas.1706928115 |
0.603 |
|
| 2018 |
Nanbo A, Maruyama J, Imai M, Ujie M, Fujioka Y, Nishide S, Takada A, Ohba Y, Kawaoka Y. Ebola virus requires a host scramblase for externalization of phosphatidylserine on the surface of viral particles. Plos Pathogens. 14. PMID 29338048 DOI: 10.1371/Journal.Ppat.1006848 |
0.394 |
|
| 2018 |
Oishi K, Yamayoshi S, Kawaoka Y. Identification of novel amino acid residues of influenza virus PA-X that are important for PA-X shutoff activity by using yeast. Virology. 516: 71-75. PMID 29331676 DOI: 10.1016/J.Virol.2018.01.004 |
0.335 |
|
| 2018 |
Nakatsu S, Murakami S, Shindo K, Horimoto T, Sagara H, Noda T, Kawaoka Y. Influenza C and D Viruses Package Eight Organized Ribonucleoprotein Complexes Journal of Virology. 92. PMID 29321324 DOI: 10.1128/Jvi.02084-17 |
0.517 |
|
| 2018 |
Noda T, Murakami S, Nakatsu S, Imai H, Muramoto Y, Shindo K, Sagara H, Kawaoka Y. Importance of the 1+7 configuration of ribonucleoprotein complexes for influenza A virus genome packaging. Nature Communications. 9: 54-54. PMID 29302061 DOI: 10.1038/S41467-017-02517-W |
0.504 |
|
| 2018 |
Hatta M, Zhong G, Gao Y, Nakajima N, Fan S, Chiba S, Deering KM, Ito M, Imai M, Kiso M, Nakatsu S, Lopes TJ, Thompson AJ, McBride R, Suarez DL, ... ... Kawaoka Y, et al. Characterization of a Feline Influenza A(H7N2) Virus. Emerging Infectious Diseases. 24: 75-86. PMID 29260686 DOI: 10.3201/Eid2401.171240 |
0.666 |
|
| 2018 |
Zhong G, Le MQ, Lopes TJS, Halfmann P, Hatta M, Fan S, Neumann G, Kawaoka Y. Mutations in the PA Protein of Avian H5N1 Influenza Viruses Affect Polymerase Activity and Mouse Virulence. Journal of Virology. 92. PMID 29212927 DOI: 10.1128/Jvi.01557-17 |
0.665 |
|
| 2018 |
Wu NC, Yamayoshi S, Ito M, Uraki R, Kawaoka Y, Wilson IA. The D3-9 gene segment encodes for recurring and adaptable binding motifs in broadly neutralizing antibodies to influenza virus Cell Host & Microbe. DOI: 10.2210/Pdb6E3H/Pdb |
0.544 |
|
| 2018 |
Sugita Y, Matsunami H, Kawaoka Y, Noda T, Wolf M. Cryo-EM structure of the Ebola virus nucleoprotein-RNA complex at 3.6 angstrom resolution. Nature. 563: 137-140. DOI: 10.2210/Pdb5Z9W/Pdb |
0.401 |
|
| 2018 |
Eiden J, Gordon G, Fierro C, Belshe R, Greenberg H, Hoft D, Hatta Y, Imboden M, Moser M, Herber R, Boltz D, Tary-Lehmann M, Kawaoka Y, Neumann G, Radspinner P, et al. 1970. Phase 1 Clinical Trial of Intranasal Immunization with M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR): Safety and Immune Response in Adults Open Forum Infectious Diseases. 5. DOI: 10.1093/Ofid/Ofy210.1626 |
0.369 |
|
| 2018 |
Becker S, Feldmann H, Geisbert T, Kawaoka Y. Marburg and Ebola Viruses – Marking 50 Years Since Their Discovery The Journal of Infectious Diseases. 218: Si-Si. DOI: 10.1093/Infdis/Jiy674 |
0.455 |
|
| 2018 |
Wang M, Fukuyama S, Kawaoka Y, Shoemaker JE. Predicting host immune cell dynamics using tissue gene expression Ifac-Papersonline. 51: 5-6. DOI: 10.1016/J.Ifacol.2018.09.005 |
0.323 |
|
| 2017 |
Yasuhara A, Yamayoshi S, Soni P, Takenaga T, Kawakami C, Takashita E, Sakai-Tagawa Y, Uraki R, Ito M, Iwatsuki-Horimoto K, Sasaki T, Ikuta K, Yamada S, Kawaoka Y. Diversity of antigenic mutants of influenza A(H1N1)pdm09 virus escaped from human monoclonal antibodies. Scientific Reports. 7: 17735. PMID 29255273 DOI: 10.1038/S41598-017-17986-8 |
0.596 |
|
| 2017 |
Yamayoshi S, Ito M, Uraki R, Sasaki T, Ikuta K, Kawaoka Y. Human protective monoclonal antibodies against the HA stem of group 2 HAs derived from an H3N2 virus-infected human. Journal of Infection. 76: 177-185. PMID 29248585 DOI: 10.1016/J.Jinf.2017.12.004 |
0.56 |
|
| 2017 |
Iwatsuki-Horimoto K, Nakajima N, Ichiko Y, Sakai-Tagawa Y, Noda T, Hasegawa H, Kawaoka Y. Syrian Hamster as an Animal Model for the Study of Human Influenza Virus Infection. Journal of Virology. 92. PMID 29212926 DOI: 10.1128/Jvi.01693-17 |
0.69 |
|
| 2017 |
Kiso M, Lopes TJS, Yamayoshi S, Ito M, Yamashita M, Nakajima N, Hasegawa H, Neumann G, Kawaoka Y. Combination Therapy with Neuraminidase and Polymerase Inhibitors in Nude Mice Infected with Influenza Virus. The Journal of Infectious Diseases. PMID 29186472 DOI: 10.1093/Infdis/Jix606 |
0.546 |
|
| 2017 |
Eisfeld AJ, Halfmann PJ, Wendler JP, Kyle JE, Burnum-Johnson KE, Peralta Z, Maemura T, Walters KB, Watanabe T, Fukuyama S, Yamashita M, Jacobs JM, Kim YM, Casey CP, Stratton KG, ... ... Kawaoka Y, et al. Multi-platform 'Omics Analysis of Human Ebola Virus Disease Pathogenesis. Cell Host & Microbe. PMID 29154144 DOI: 10.1016/J.Chom.2017.10.011 |
0.534 |
|
| 2017 |
Sakai-Tagawa Y, Yamayoshi S, Kawakami C, Le MQ, Uchida Y, Saito T, Nidom CA, Humaira I, Toohey-Kurth K, Arafa AS, Liu MT, Shu Y, Kawaoka Y. Reactivity and sensitivity of commercially available influenza rapid diagnostic tests in Japan. Scientific Reports. 7: 14483. PMID 29101372 DOI: 10.1038/S41598-017-14536-0 |
0.602 |
|
| 2017 |
Watanabe T, Imai M, Kawaoka Y. NS1 is the fluid for "flu-transmission". Proceedings of the National Academy of Sciences of the United States of America. 114: 11012-11014. PMID 29073013 DOI: 10.1073/Pnas.1715239114 |
0.626 |
|
| 2017 |
Imai M, Watanabe T, Kiso M, Nakajima N, Yamayoshi S, Iwatsuki-Horimoto K, Hatta M, Yamada S, Ito M, Sakai-Tagawa Y, Shirakura M, Takashita E, Fujisaki S, McBride R, Thompson AJ, ... ... Kawaoka Y, et al. A Highly Pathogenic Avian H7N9 Influenza Virus Isolated from A Human Is Lethal in Some Ferrets Infected via Respiratory Droplets. Cell Host & Microbe. PMID 29056430 DOI: 10.1016/J.Chom.2017.09.008 |
0.675 |
|
| 2017 |
Kiso M, Iwatsuki-Horimoto K, Yamayoshi S, Uraki R, Ito M, Nakajima N, Yamada S, Imai M, Kawakami E, Tomita Y, Fukuyama S, Itoh Y, Ogasawara K, Lopes TJS, Watanabe T, ... ... Kawaoka Y, et al. Emergence of Oseltamivir-Resistant H7N9 Influenza Viruses in Immunosuppressed Cynomolgus Macaques. The Journal of Infectious Diseases. 216: 582-593. PMID 28931216 DOI: 10.1093/Infdis/Jix296 |
0.632 |
|
| 2017 |
Eisfeld AJ, Kawaoka Y. Calculated risk: a new single-nucleotide polymorphism linked to severe influenza disease. Nature Medicine. 23: 911-912. PMID 28777788 DOI: 10.1038/Nm.4383 |
0.496 |
|
| 2017 |
Hatta Y, Boltz D, Sarawar S, Kawaoka Y, Neumann G, Bilsel P. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza. Vaccine. 35: 4177-4183. PMID 28668565 DOI: 10.1016/J.Vaccine.2017.06.039 |
0.636 |
|
| 2017 |
Yamayoshi S, Kawaoka Y. Ebolavirus’s Foibles Cell. 169: 773-775. PMID 28525748 DOI: 10.1016/J.Cell.2017.05.008 |
0.344 |
|
| 2017 |
Yamayoshi S, Uraki R, Ito M, Kiso M, Nakatsu S, Yasuhara A, Oishi K, Sasaki T, Ikuta K, Kawaoka Y. A Broadly Reactive Human Anti-hemagglutinin Stem Monoclonal Antibody That Inhibits Influenza A Virus Particle Release. Ebiomedicine. PMID 28286060 DOI: 10.1016/J.Ebiom.2017.03.007 |
0.537 |
|
| 2017 |
Ui H, Yamayoshi S, Uraki R, Kiso M, Oishi K, Murakami S, Mimori S, Kawaoka Y. Evaluation of seasonal influenza vaccines for H1N1pdm09 and type B viruses based on a replication-incompetent PB2-KO virus. Vaccine. 35: 1892-1897. PMID 28285982 DOI: 10.1016/J.Vaccine.2017.02.041 |
0.633 |
|
| 2017 |
Nakayama M, Itoh Y, Shichinohe S, Nakabayashi R, Ishigaki H, Sakoda Y, Le QM, Kawaoka Y, Kida H, Ogasawara K. Potential risk of repeated nasal vaccination that induces allergic reaction with mucosal IgE and airway eosinophilic infiltration in cynomolgus macaques infected with H5N1 highly pathogenic avian influenza virus Vaccine. 35: 1008-1017. PMID 28109707 DOI: 10.1016/J.Vaccine.2017.01.008 |
0.536 |
|
| 2017 |
Zhao D, Liang L, Wang S, Nakao T, Li Y, Liu L, Guan Y, Fukuyama S, Bu Z, Kawaoka Y, Chen H. Glycosylation of the HA protein of H5N1 virus increases its virulence in mice by exacerbating the host immune response. Journal of Virology. PMID 28100622 DOI: 10.1128/Jvi.02215-16 |
0.656 |
|
| 2017 |
Burnum-Johnson KE, Kyle JE, Eisfeld AJ, Casey CP, Stratton KG, Gonzalez JF, Habyarimana F, Negretti NM, Sims AC, Chauhan S, Thackray LB, Halfmann PJ, Walters KB, Kim YM, Zink EM, ... ... Kawaoka Y, et al. MPLEx: a method for simultaneous pathogen inactivation and extraction of samples for multi-omics profiling. The Analyst. PMID 28091625 DOI: 10.1039/C6An02486F |
0.449 |
|
| 2016 |
Watanabe T, Kawaoka Y. Neo-Virology: the raison d'etre of viruses. Uirusu. 66: 155-162. PMID 29081467 DOI: 10.2222/Jsv.66.155 |
0.504 |
|
| 2016 |
Watanabe T, Kawaoka Y. Control of Ebola hemorrhagic fever: vaccine development and our Ebola project in Sierra Leone. Uirusu. 66: 53-62. PMID 28484179 DOI: 10.2222/Jsv.66.53 |
0.566 |
|
| 2016 |
Gasper DJ, Neldner B, Plisch EH, Rustom H, Carrow E, Imai H, Kawaoka Y, Suresh M. Effective Respiratory CD8 T-Cell Immunity to Influenza Virus Induced by Intranasal Carbomer-Lecithin-Adjuvanted Non-replicating Vaccines Plos Pathogens. 12. PMID 27997610 DOI: 10.1371/Journal.Ppat.1006064 |
0.418 |
|
| 2016 |
Ping J, Lopes TJ, Neumann G, Kawaoka Y. Development of high-yield influenza B virus vaccine viruses. Proceedings of the National Academy of Sciences of the United States of America. PMID 27930325 DOI: 10.1073/Pnas.1616530113 |
0.665 |
|
| 2016 |
Arafa AS, Yamada S, Imai M, Watanabe T, Yamayoshi S, Iwatsuki-Horimoto K, Kiso M, Sakai-Tagawa Y, Ito M, Imamura T, Nakajima N, Takahashi K, Zhao D, Oishi K, Yasuhara A, ... ... Kawaoka Y, et al. Risk assessment of recent Egyptian H5N1 influenza viruses. Scientific Reports. 6: 38388. PMID 27922116 DOI: 10.1038/Srep38388 |
0.65 |
|
| 2016 |
Iwatsuki-Horimoto K, Nakajima N, Shibata M, Takahashi K, Sato Y, Kiso M, Yamayoshi S, Ito M, Enya S, Otake M, Kangawa A, da Silva Lopes TJ, Ito H, Hasegawa H, Kawaoka Y. Microminipigs as an animal model for influenza A virus infection. Journal of Virology. PMID 27807225 DOI: 10.1128/Jvi.01716-16 |
0.63 |
|
| 2016 |
Miyauchi K, Sugimoto-Ishige A, Harada Y, Adachi Y, Usami Y, Kaji T, Inoue K, Hasegawa H, Watanabe T, Hijikata A, Fukuyama S, Maemura T, Okada-Hatakeyama M, Ohara O, Kawaoka Y, et al. Protective neutralizing influenza antibody response in the absence of T follicular helper cells. Nature Immunology. PMID 27798619 DOI: 10.1038/Ni.3563 |
0.529 |
|
| 2016 |
Nakatsu S, Sagara H, Sakai-Tagawa Y, Sugaya N, Noda T, Kawaoka Y. Complete and Incomplete Genome Packaging of Influenza A and B Viruses Mbio. 7. PMID 27601575 DOI: 10.1128/Mbio.01248-16 |
0.554 |
|
| 2016 |
Sarawar S, Hatta Y, Watanabe S, Dias P, Neumann G, Kawaoka Y, Bilsel P. M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice. Vaccine. PMID 27595896 DOI: 10.1016/J.Vaccine.2016.08.061 |
0.62 |
|
| 2016 |
Ando T, Yamayoshi S, Tomita Y, Watanabe S, Watanabe T, Kawaoka Y. The host protein CLUH participates in the subnuclear transport of influenza virus ribonucleoprotein complexes. Nature Microbiology. 1: 16062. PMID 27573102 DOI: 10.1038/Nmicrobiol.2016.62 |
0.458 |
|
| 2016 |
Li C, Hatta M, Burke DF, Ping J, Zhang Y, Ozawa M, Taft AS, Das SC, Hanson AP, Song J, Imai M, Wilker PR, Watanabe T, Watanabe S, Ito M, ... ... Kawaoka Y, et al. Selection of antigenically advanced variants of seasonal influenza viruses. Nature Microbiology. 1: 16058. PMID 27572841 DOI: 10.1038/Nmicrobiol.2016.58 |
0.631 |
|
| 2016 |
Chasman D, Walters KB, Lopes TJ, Eisfeld AJ, Kawaoka Y, Roy S. Integrating Transcriptomic and Proteomic Data Using Predictive Regulatory Network Models of Host Response to Pathogens. Plos Computational Biology. 12: e1005013. PMID 27403523 DOI: 10.1371/Journal.Pcbi.1005013 |
0.397 |
|
| 2016 |
Takashita E, Ejima M, Ogawa R, Fujisaki S, Neumann G, Furuta Y, Kawaoka Y, Tashiro M, Odagiri T. Antiviral susceptibility of influenza viruses isolated from patients pre- and post-administration of favipiravir. Antiviral Research. PMID 27321665 DOI: 10.1016/J.Antiviral.2016.06.007 |
0.627 |
|
| 2016 |
Westhoff Smith D, Hill-Batorski L, N'jai A, Eisfeld AJ, Neumann G, Halfmann P, Kawaoka Y. Ebola Virus Stability Under Hospital and Environmental Conditions. The Journal of Infectious Diseases. PMID 27279525 DOI: 10.1093/Infdis/Jiw167 |
0.454 |
|
| 2016 |
Tisoncik-Go J, Gasper DJ, Kyle JE, Eisfeld AJ, Selinger C, Hatta M, Morrison J, Korth MJ, Zink EM, Kim YM, Schepmoes AA, Nicora CD, Purvine SO, Weitz KK, Peng X, ... ... Kawaoka Y, et al. Integrated Omics Analysis of Pathogenic Host Responses during Pandemic H1N1 Influenza Virus Infection: The Crucial Role of Lipid Metabolism. Cell Host & Microbe. 19: 254-66. PMID 26867183 DOI: 10.1016/J.Chom.2016.01.002 |
0.588 |
|
| 2016 |
Moncla LH, Zhong G, Nelson CW, Dinis JM, Mutschler J, Hughes AL, Watanabe T, Kawaoka Y, Friedrich TC. Selective Bottlenecks Shape Evolutionary Pathways Taken during Mammalian Adaptation of a 1918-like Avian Influenza Virus. Cell Host & Microbe. 19: 169-80. PMID 26867176 DOI: 10.1016/J.Chom.2016.01.011 |
0.628 |
|
| 2016 |
Fujimoto Y, Ito H, Ono E, Kawaoka Y, Ito T. The Low-pH Resistance of Neuraminidase Is Essential for the Replication of Influenza A Virus in Duck Intestine following Infection via the Oral Route. Journal of Virology. 90: 4127-4132. PMID 26865722 DOI: 10.1128/JVI.03107-15 |
0.498 |
|
| 2016 |
Katsura H, Fukuyama S, Watanabe S, Ozawa M, Neumann G, Kawaoka Y. Amino acid changes in PB2 and HA affect the growth of a recombinant influenza virus expressing a fluorescent reporter protein. Scientific Reports. 6: 19933. PMID 26847414 DOI: 10.1038/Srep19933 |
0.614 |
|
| 2016 |
Pécheur EI, Borisevich V, Halfmann P, Morrey JD, Smee DF, Prichard M, Mire CE, Kawaoka Y, Geisbert TW, Polyak SJ. The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses. Journal of Virology. PMID 26739045 DOI: 10.1128/Jvi.02077-15 |
0.562 |
|
| 2016 |
Yang H, Chen Y, Qiao C, He X, Zhou H, Sun Y, Yin H, Meng S, Liu L, Zhang Q, Kong H, Gu C, Li C, Bu Z, Kawaoka Y, et al. Prevalence, genetics, and transmissibility in ferrets of Eurasian avian-like H1N1 swine influenza viruses. Proceedings of the National Academy of Sciences of the United States of America. 113: 392-7. PMID 26711995 DOI: 10.1073/Pnas.1522643113 |
0.656 |
|
| 2016 |
Fujimoto Y, Ito H, Ono E, Kawaoka Y, Ito T. The low-pH resistance of neuraminidase is essential for the replication of influenza A virus in duck intestine following infection via the oral route Journal of Virology. 90: 4127-4132. DOI: 10.1128/Jvi.03107-15 |
0.579 |
|
| 2016 |
Dye J, Chandran K, Kobinger G, Kawaoka Y, Zeitlin L, Ward A, Nykiforuk C, Aman J, Lai J, Saphire E. E-105 Antibodies against ebola virus Jaids Journal of Acquired Immune Deficiency Syndromes. 71: 58. DOI: 10.1097/01.Qai.0000479621.47644.67 |
0.479 |
|
| 2016 |
Sugita Y, Kawaoka Y, Noda T, Wolf M. Structure of the Ebola Virus Nucleocapsid Core by Single Particle Cryo-Electron Microscopy Microscopy and Microanalysis. 22: 66-67. DOI: 10.1017/S1431927616001185 |
0.406 |
|
| 2015 |
Hanson A, Imai M, Hatta M, McBride R, Imai H, Taft A, Zhong G, Watanabe T, Suzuki Y, Neumann G, Paulson JC, Kawaoka Y. Identification of Stabilizing Mutations in an H5 HA Influenza Virus Protein. Journal of Virology. PMID 26719265 DOI: 10.1128/Jvi.02790-15 |
0.6 |
|
| 2015 |
Zhao D, Fukuyama S, Sakai-Tagawa Y, Takashita E, Shoemaker JE, Kawaoka Y. C646, a novel p300/CREB-binding protein-specific inhibitor of histone acetyltransferase, attenuates influenza A virus infection. Antimicrobial Agents and Chemotherapy. PMID 26711748 DOI: 10.1128/Aac.02055-15 |
0.591 |
|
| 2015 |
Forero A, Tisoncik-Go J, Watanabe T, Zhong G, Hatta M, Tchitchek N, Selinger C, Chang J, Barker K, Morrison J, Berndt JD, Moon RT, Josset L, Kawaoka Y, Katze MG. The 1918 PB2 protein enhances virulence through the disruption of inflammatory and Wnt-mediated signaling in mice. Journal of Virology. PMID 26656717 DOI: 10.1128/Jvi.02974-15 |
0.631 |
|
| 2015 |
Oda SI, Noda T, Wijesinghe KJ, Halfmann P, Bornholdt ZA, Abelson DM, Armbrust T, Stahelin RV, Kawaoka Y, Saphire EO. Crystal structure of Marburg virus VP40: matrix assembly and immunosuppression. Journal of Virology. PMID 26656687 DOI: 10.1128/Jvi.01597-15 |
0.52 |
|
| 2015 |
Yamayoshi S, Watanabe M, Goto H, Kawaoka Y. Identification of A Novel Viral Protein Expressed from the PB2 Segment of Influenza A Virus. Journal of Virology. PMID 26491155 DOI: 10.1128/Jvi.02175-15 |
0.641 |
|
| 2015 |
Watanabe T, Kawaoka Y. Influenza virus-host interactomes as a basis for antiviral drug development. Current Opinion in Virology. 14: 71-78. PMID 26364134 DOI: 10.1016/J.Coviro.2015.08.008 |
0.627 |
|
| 2015 |
Zhao D, Fukuyama S, Yamada S, Lopes TJ, Maemura T, Katsura H, Ozawa M, Watanabe S, Neumann G, Kawaoka Y. Molecular determinants of virulence and stability of a reporter-expressing H5N1 influenza A virus. Journal of Virology. PMID 26339046 DOI: 10.1128/Jvi.01886-15 |
0.686 |
|
| 2015 |
Ping J, Lopes TJ, Nidom CA, Ghedin E, Macken CA, Fitch A, Imai M, Maher EA, Neumann G, Kawaoka Y. Development of high-yield influenza A virus vaccine viruses. Nature Communications. 6: 8148. PMID 26334134 DOI: 10.1038/Ncomms9148 |
0.58 |
|
| 2015 |
Okumura A, Rasmussen AL, Halfmann P, Feldmann F, Yoshimura A, Feldmann H, Kawaoka Y, Harty RN, Katze MG. Suppressor of Cytokine Signaling 3 Is an Inducible Host Factor That Regulates Virus Egress during Ebola Virus Infection. Journal of Virology. 89: 10399-406. PMID 26246577 DOI: 10.1128/Jvi.01736-15 |
0.542 |
|
| 2015 |
Okazaki T, Higuchi M, Takeda K, Iwatsuki-Horimoto K, Kiso M, Miyagishi M, Yanai H, Kato A, Yoneyama M, Fujita T, Taniguchi T, Kawaoka Y, Ichijo H, Gotoh Y. The ASK family kinases differentially mediate induction of type I interferon and apoptosis during the antiviral response. Science Signaling. 8: ra78. PMID 26243192 DOI: 10.1126/Scisignal.Aab1883 |
0.394 |
|
| 2015 |
Uraki R, Piao Z, Akeda Y, Iwatsuki-Horimoto K, Kiso M, Ozawa M, Oishi K, Kawaoka Y. A Bivalent Vaccine Based on a PB2-Knockout Influenza Virus Protects Mice From Secondary Pneumococcal Pneumonia. The Journal of Infectious Diseases. 212: 1939-48. PMID 26123562 DOI: 10.1093/Infdis/Jiv341 |
0.636 |
|
| 2015 |
Taft AS, Ozawa M, Fitch A, Depasse JV, Halfmann PJ, Hill-Batorski L, Hatta M, Friedrich TC, Lopes TJ, Maher EA, Ghedin E, Macken CA, Neumann G, Kawaoka Y. Identification of mammalian-adapting mutations in the polymerase complex of an avian H5N1 influenza virus. Nature Communications. 6: 7491. PMID 26082035 DOI: 10.1038/Ncomms8491 |
0.685 |
|
| 2015 |
Shoemaker JE, Fukuyama S, Eisfeld AJ, Zhao D, Kawakami E, Sakabe S, Maemura T, Gorai T, Katsura H, Muramoto Y, Watanabe S, Watanabe T, Fuji K, Matsuoka Y, Kitano H, ... Kawaoka Y, et al. An Ultrasensitive Mechanism Regulates Influenza Virus-Induced Inflammation. Plos Pathogens. 11: e1004856. PMID 26046528 DOI: 10.1371/Journal.Ppat.1004856 |
0.575 |
|
| 2015 |
Oishi K, Yamayoshi S, Kawaoka Y. Mapping of a Region of the PA-X Protein of Influenza A Virus That Is Important for Its Shutoff Activity. Journal of Virology. 89: 8661-5. PMID 26041295 DOI: 10.1128/Jvi.01132-15 |
0.411 |
|
| 2015 |
Horimoto T, Gen F, Murakami S, Iwatsuki-Horimoto K, Kato K, Hisasue M, Sakaguchi M, Nidom CA, Kawaoka Y. Cats as a potential source of emerging influenza virus infections. Virologica Sinica. 30: 221-3. PMID 25953615 DOI: 10.1007/S12250-015-3580-9 |
0.669 |
|
| 2015 |
Chin AW, Perera RA, Guan Y, Halfmann P, Kawaoka Y, Peiris M, Poon LL. Pseudoparticle neutralization assay for detecting ebola- neutralizing antibodies in biosafety level 2 settings. Clinical Chemistry. 61: 885-6. PMID 25829407 DOI: 10.1373/Clinchem.2015.238204 |
0.533 |
|
| 2015 |
Marzi A, Halfmann P, Hill-Batorski L, Feldmann F, Shupert WL, Neumann G, Feldmann H, Kawaoka Y. Vaccines. An Ebola whole-virus vaccine is protective in nonhuman primates. Science (New York, N.Y.). 348: 439-42. PMID 25814063 DOI: 10.1126/Science.Aaa4919 |
0.444 |
|
| 2015 |
Neumann G, Kawaoka Y. Transmission of influenza A viruses. Virology. 479: 234-46. PMID 25812763 DOI: 10.1016/J.Virol.2015.03.009 |
0.693 |
|
| 2015 |
Fukuyama S, Katsura H, Zhao D, Ozawa M, Ando T, Shoemaker JE, Ishikawa I, Yamada S, Neumann G, Watanabe S, Kitano H, Kawaoka Y. Multi-spectral fluorescent reporter influenza viruses (Color-flu) as powerful tools for in vivo studies. Nature Communications. 6: 6600. PMID 25807527 DOI: 10.1038/Ncomms7600 |
0.66 |
|
| 2015 |
Takashita E, Kiso M, Fujisaki S, Yokoyama M, Nakamura K, Shirakura M, Sato H, Odagiri T, Kawaoka Y, Tashiro M. Characterization of a large cluster of influenza A(H1N1)pdm09 viruses cross-resistant to oseltamivir and peramivir during the 2013-2014 influenza season in Japan. Antimicrobial Agents and Chemotherapy. 59: 2607-17. PMID 25691635 DOI: 10.1128/Aac.04836-14 |
0.615 |
|
| 2015 |
Yamaji R, Yamada S, Le MQ, Ito M, Sakai-Tagawa Y, Kawaoka Y. Mammalian adaptive mutations of the PA protein of highly pathogenic avian H5N1 influenza virus. Journal of Virology. 89: 4117-25. PMID 25631084 DOI: 10.1128/Jvi.03532-14 |
0.665 |
|
| 2015 |
Yamayoshi S, Fukuyama S, Yamada S, Zhao D, Murakami S, Uraki R, Watanabe T, Tomita Y, Neumann G, Kawaoka Y. Amino acids substitutions in the PB2 protein of H7N9 influenza A viruses are important for virulence in mammalian hosts. Scientific Reports. 5: 8039. PMID 25623817 DOI: 10.1038/Srep08039 |
0.588 |
|
| 2015 |
Yamaji R, Yamada S, Le MQ, Li C, Chen H, Qurnianingsih E, Nidom CA, Ito M, Sakai-Tagawa Y, Kawaoka Y. Identification of PB2 mutations responsible for the efficient replication of H5N1 influenza viruses in human lung epithelial cells. Journal of Virology. 89: 3947-56. PMID 25609813 DOI: 10.1128/Jvi.03328-14 |
0.657 |
|
| 2015 |
Eisfeld AJ, Neumann G, Kawaoka Y. At the centre: influenza A virus ribonucleoproteins. Nature Reviews. Microbiology. 13: 28-41. PMID 25417656 DOI: 10.1038/Nrmicro3367 |
0.632 |
|
| 2015 |
Sugaya N, Sakai-Tagawa Y, Bamba M, Yasuhara R, Yamazaki M, Kawakami C, Yamaguchi Y, Ide Y, Ichikawa M, Mitamura K, Kawaoka Y. Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor. Antiviral Therapy. 20: 49-55. PMID 24832015 DOI: 10.3851/Imp2798 |
0.653 |
|
| 2015 |
Shiraishi K, Mitamura K, Ozawa M, Kakugawa S, Kiso M, Sakai-Tagawa Y, Sugaya N, Kawaoka Y. Mutations in influenza A virus during amantadine-oseltamivir combination therapy Journal of Pediatric Infectious Diseases. 5: 243-248. DOI: 10.3233/Jpi-2010-0256 |
0.562 |
|
| 2014 |
Halfmann P, Neumann G, Feldmann H, Kawaoka Y. Ebola Conquers West Africa - More to Come? Ebiomedicine. 1: 2-3. PMID 26137502 DOI: 10.1016/J.Ebiom.2014.10.004 |
0.481 |
|
| 2014 |
Aevermann BD, Pickett BE, Kumar S, Klem EB, Agnihothram S, Askovich PS, Bankhead A, Bolles M, Carter V, Chang J, Clauss TR, Dash P, Diercks AH, Eisfeld AJ, Ellis A, ... ... Kawaoka Y, et al. A comprehensive collection of systems biology data characterizing the host response to viral infection. Scientific Data. 1: 140033. PMID 25977790 DOI: 10.1038/Sdata.2014.33 |
0.353 |
|
| 2014 |
Watanabe T, Kawakami E, Shoemaker JE, Lopes TJ, Matsuoka Y, Tomita Y, Kozuka-Hata H, Gorai T, Kuwahara T, Takeda E, Nagata A, Takano R, Kiso M, Yamashita M, Sakai-Tagawa Y, ... ... Kawaoka Y, et al. Influenza virus-host interactome screen as a platform for antiviral drug development. Cell Host & Microbe. 16: 795-805. PMID 25464832 DOI: 10.1016/J.Chom.2014.11.002 |
0.531 |
|
| 2014 |
Li X, Shi J, Guo J, Deng G, Zhang Q, Wang J, He X, Wang K, Chen J, Li Y, Fan J, Kong H, Gu C, Guan Y, Suzuki Y, ... Kawaoka Y, et al. Genetics, receptor binding property, and transmissibility in mammals of naturally isolated H9N2 Avian Influenza viruses. Plos Pathogens. 10: e1004508. PMID 25411973 DOI: 10.1371/Journal.Ppat.1004508 |
0.67 |
|
| 2014 |
Peng X, Alföldi J, Gori K, Eisfeld AJ, Tyler SR, Tisoncik-Go J, Brawand D, Law GL, Skunca N, Hatta M, Gasper DJ, Kelly SM, Chang J, Thomas MJ, Johnson J, ... ... Kawaoka Y, et al. The draft genome sequence of the ferret (Mustela putorius furo) facilitates study of human respiratory disease. Nature Biotechnology. 32: 1250-5. PMID 25402615 DOI: 10.1038/Nbt.3079 |
0.55 |
|
| 2014 |
Eisfeld AJ, Neumann G, Kawaoka Y. Influenza A virus isolation, culture and identification. Nature Protocols. 9: 2663-81. PMID 25321410 DOI: 10.1038/Nprot.2014.180 |
0.557 |
|
| 2014 |
Fan S, Hatta M, Kim JH, Halfmann P, Imai M, Macken CA, Le MQ, Nguyen T, Neumann G, Kawaoka Y. Novel residues in avian influenza virus PB2 protein affect virulence in mammalian hosts. Nature Communications. 5: 5021. PMID 25289523 DOI: 10.1038/Ncomms6021 |
0.577 |
|
| 2014 |
Watanabe T, Watanabe S, Maher EA, Neumann G, Kawaoka Y. Pandemic potential of avian influenza A (H7N9) viruses. Trends in Microbiology. 22: 623-31. PMID 25264312 DOI: 10.1016/J.Tim.2014.08.008 |
0.66 |
|
| 2014 |
Fan S, Hatta M, Kim JH, Le MQ, Neumann G, Kawaoka Y. Amino acid changes in the influenza A virus PA protein that attenuate avian H5N1 viruses in mammals. Journal of Virology. 88: 13737-46. PMID 25231317 DOI: 10.1128/Jvi.01081-14 |
0.666 |
|
| 2014 |
Florek NW, Weinfurter JT, Jegaskanda S, Brewoo JN, Powell TD, Young GR, Das SC, Hatta M, Broman KW, Hungnes O, Dudman SG, Kawaoka Y, Kent SJ, Stinchcomb DT, Osorio JE, et al. Modified vaccinia virus Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques. Journal of Virology. 88: 13418-28. PMID 25210172 DOI: 10.1128/Jvi.01219-14 |
0.594 |
|
| 2014 |
Katsura H, Piao Z, Iwatsuki-Horimoto K, Akeda Y, Watanabe S, Horimoto T, Oishi K, Kawaoka Y. A bivalent vaccine based on a replication-incompetent influenza virus protects against Streptococcus pneumoniae and influenza virus infection. Journal of Virology. 88: 13410-7. PMID 25210171 DOI: 10.1128/Jvi.01205-14 |
0.685 |
|
| 2014 |
Uraki R, Das SC, Hatta M, Kiso M, Iwatsuki-Horimoto K, Ozawa M, Coban C, Ishii KJ, Kawaoka Y. Hemozoin as a novel adjuvant for inactivated whole virion influenza vaccine. Vaccine. 32: 5295-300. PMID 25108216 DOI: 10.1016/J.Vaccine.2014.07.079 |
0.539 |
|
| 2014 |
Nagaoka M, Hatta Y, Kawaoka Y, Malherbe LP. Antigen signal strength during priming determines effector CD4 T cell function and antigen sensitivity during influenza virus challenge. Journal of Immunology (Baltimore, Md. : 1950). 193: 2812-20. PMID 25086170 DOI: 10.4049/Jimmunol.1401358 |
0.364 |
|
| 2014 |
Sakai-Tagawa Y, Ozawa M, Yamada S, Uchida Y, Saito T, Takahashi K, Sugaya N, Tashiro M, Kawaoka Y. Detection sensitivity of influenza rapid diagnostic tests. Microbiology and Immunology. 58: 600-6. PMID 25079880 DOI: 10.1111/1348-0421.12185 |
0.585 |
|
| 2014 |
Hatakeyama D, Shoji M, Yamayoshi S, Hirota T, Nagae M, Yanagisawa S, Nakano M, Ohmi N, Noda T, Kawaoka Y, Kuzuhara T. A novel functional site in the PB2 subunit of influenza A virus essential for acetyl-CoA interaction, RNA polymerase activity, and viral replication. The Journal of Biological Chemistry. 289: 24980-94. PMID 25063805 DOI: 10.1074/Jbc.M114.559708 |
0.455 |
|
| 2014 |
Herfst S, Imai M, Kawaoka Y, Fouchier RAM. Avian influenza virus transmission to mammals Current Topics in Microbiology and Immunology. 385: 137-155. PMID 25048542 DOI: 10.1007/82_2014_387 |
0.659 |
|
| 2014 |
Garulli B, Di Mario G, Stillitano MG, Compagnoni D, Titti F, Cafaro A, Ensoli B, Kawaoka Y, Castrucci MR. Induction of antibodies and t cell responses by a recombinant influenza virus carrying an HIV-1 Tat Δ51-59 protein in mice Biomed Research International. 2014. PMID 24949479 DOI: 10.1155/2014/904038 |
0.618 |
|
| 2014 |
Itoh Y, Yoshida R, Shichinohe S, Higuchi M, Ishigaki H, Nakayama M, Pham VL, Ishida H, Kitano M, Arikata M, Kitagawa N, Mitsuishi Y, Ogasawara K, Tsuchiya H, Hiono T, ... ... Kawaoka Y, et al. Protective efficacy of passive immunization with monoclonal antibodies in animal models of H5N1 highly pathogenic avian influenza virus infection. Plos Pathogens. 10: e1004192. PMID 24945244 DOI: 10.1371/Journal.Ppat.1004192 |
0.585 |
|
| 2014 |
Watanabe T, Zhong G, Russell CA, Nakajima N, Hatta M, Hanson A, McBride R, Burke DF, Takahashi K, Fukuyama S, Tomita Y, Maher EA, Watanabe S, Imai M, Neumann G, ... ... Kawaoka Y, et al. Circulating avian influenza viruses closely related to the 1918 virus have pandemic potential. Cell Host & Microbe. 15: 692-705. PMID 24922572 DOI: 10.1016/J.Chom.2014.05.006 |
0.699 |
|
| 2014 |
Josset L, Tchitchek N, Gralinski LE, Ferris MT, Eisfeld AJ, Green RR, Thomas MJ, Tisoncik-Go J, Schroth GP, Kawaoka Y, Manuel de Villena FP, Baric RS, Heise MT, Peng X, Katze MG. Annotation of long non-coding RNAs expressed in collaborative cross founder mice in response to respiratory virus infection reveals a new class of interferon-stimulated transcripts. Rna Biology. 11: 875-90. PMID 24922324 DOI: 10.4161/Rna.29442 |
0.449 |
|
| 2014 |
Kitano M, Itoh Y, Ishigaki H, Nakayama M, Ishida H, Pham VL, Arikata M, Shichinohe S, Tsuchiya H, Kitagawa N, Kobayashi M, Yoshida R, Sato A, Le QM, Kawaoka Y, et al. Efficacy of repeated intravenous administration of peramivir against highly pathogenic avian influenza A (H5N1) virus in cynomolgus macaques. Antimicrobial Agents and Chemotherapy. 58: 4795-803. PMID 24913156 DOI: 10.1128/Aac.02817-14 |
0.607 |
|
| 2014 |
Muramoto Y, Shoemaker JE, Le MQ, Itoh Y, Tamura D, Sakai-Tagawa Y, Imai H, Uraki R, Takano R, Kawakami E, Ito M, Okamoto K, Ishigaki H, Mimuro H, Sasakawa C, ... ... Kawaoka Y, et al. Disease severity is associated with differential gene expression at the early and late phases of infection in nonhuman primates infected with different H5N1 highly pathogenic avian influenza viruses. Journal of Virology. 88: 8981-97. PMID 24899188 DOI: 10.1128/Jvi.00907-14 |
0.558 |
|
| 2014 |
Menachery VD, Eisfeld AJ, Schäfer A, Josset L, Sims AC, Proll S, Fan S, Li C, Neumann G, Tilton SC, Chang J, Gralinski LE, Long C, Green R, Williams CM, ... ... Kawaoka Y, et al. Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses. Mbio. 5: e01174-14. PMID 24846384 DOI: 10.1128/Mbio.01174-14 |
0.626 |
|
| 2014 |
Kurebayashi Y, Takahashi T, Otsubo T, Ikeda K, Takahashi S, Takano M, Agarikuchi T, Sato T, Matsuda Y, Minami A, Kanazawa H, Uchida Y, Saito T, Kawaoka Y, Yamada T, et al. Imaging of influenza virus sialidase activity in living cells. Scientific Reports. 4: 4877. PMID 24786761 DOI: 10.1038/Srep04877 |
0.662 |
|
| 2014 |
Tani H, Iha K, Shimojima M, Fukushi S, Taniguchi S, Yoshikawa T, Kawaoka Y, Nakasone N, Ninomiya H, Saijo M, Morikawa S. Analysis of Lujo virus cell entry using pseudotype vesicular stomatitis virus. Journal of Virology. 88: 7317-30. PMID 24741091 DOI: 10.1128/Jvi.00512-14 |
0.544 |
|
| 2014 |
Garulli B, Di Mario G, Stillitano MG, Kawaoka Y, Castrucci MR. Exploring mucosal immunization with a recombinant influenza virus carrying an HIV-polyepitope in mice with pre-existing immunity to influenza. Vaccine. 32: 2501-6. PMID 24662706 DOI: 10.1016/J.Vaccine.2014.02.077 |
0.484 |
|
| 2014 |
Teijaro JR, Walsh KB, Long JP, Tordoff KP, Stark GV, Eisfeld AJ, Kawaoka Y, Rosen H, Oldstone MB. Protection of ferrets from pulmonary injury due to H1N1 2009 influenza virus infection: immunopathology tractable by sphingosine-1-phosphate 1 receptor agonist therapy. Virology. 452: 152-7. PMID 24606692 DOI: 10.1016/J.Virol.2014.01.003 |
0.544 |
|
| 2014 |
Sakai K, Ami Y, Tahara M, Kubota T, Anraku M, Abe M, Nakajima N, Sekizuka T, Shirato K, Suzaki Y, Ainai A, Nakatsu Y, Kanou K, Nakamura K, Suzuki T, ... ... Kawaoka Y, et al. The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses. Journal of Virology. 88: 5608-16. PMID 24600012 DOI: 10.1128/Jvi.03677-13 |
0.578 |
|
| 2014 |
Neumann G, Macken CA, Kawaoka Y. Identification of amino acid changes that may have been critical for the genesis of A(H7N9) influenza viruses. Journal of Virology. 88: 4877-96. PMID 24522919 DOI: 10.1128/Jvi.00107-14 |
0.658 |
|
| 2014 |
Liu Z, Kato A, Shindo K, Noda T, Sagara H, Kawaoka Y, Arii J, Kawaguchi Y. Herpes simplex virus 1 UL47 interacts with viral nuclear egress factors UL31, UL34, and Us3 and regulates viral nuclear egress. Journal of Virology. 88: 4657-67. PMID 24522907 DOI: 10.1128/Jvi.00137-14 |
0.488 |
|
| 2014 |
Wang G, Deng G, Shi J, Luo W, Zhang G, Zhang Q, Liu L, Jiang Y, Li C, Sriwilaijaroen N, Hiramatsu H, Suzuki Y, Kawaoka Y, Chen H. H6 influenza viruses pose a potential threat to human health. Journal of Virology. 88: 3953-64. PMID 24501418 DOI: 10.1128/Jvi.03292-13 |
0.576 |
|
| 2014 |
Castrucci MR, Facchini M, Di Mario G, Garulli B, Sciaraffia E, Meola M, Fabiani C, De Marco MA, Cordioli P, Siccardi A, Kawaoka Y, Donatelli I. Modified vaccinia virus Ankara expressing the hemagglutinin of pandemic (H1N1) 2009 virus induces cross-protective immunity against Eurasian 'avian-like' H1N1 swine viruses in mice. Influenza and Other Respiratory Viruses. 8: 367-75. PMID 24373385 DOI: 10.1111/Irv.12221 |
0.637 |
|
| 2014 |
Yamayoshi S, Yamada S, Fukuyama S, Murakami S, Zhao D, Uraki R, Watanabe T, Tomita Y, Macken C, Neumann G, Kawaoka Y. Virulence-affecting amino acid changes in the PA protein of H7N9 influenza A viruses. Journal of Virology. 88: 3127-34. PMID 24371069 DOI: 10.1128/Jvi.03155-13 |
0.616 |
|
| 2014 |
Horimoto T, Gen F, Murakami S, Iwatsuki-Horimoto K, Kato K, Akashi H, Hisasue M, Sakaguchi M, Kawaoka Y, Maeda K. Serological evidence of infection of dogs with human influenza viruses in Japan. The Veterinary Record. 174: 96. PMID 24336761 DOI: 10.1136/Vr.101929 |
0.661 |
|
| 2014 |
Fonseca W, Ozawa M, Hatta M, Orozco E, Martínez MB, Kawaoka Y. A recombinant influenza virus vaccine expressing the F protein of respiratory syncytial virus. Archives of Virology. 159: 1067-77. PMID 24292020 DOI: 10.1007/S00705-013-1932-Z |
0.677 |
|
| 2014 |
de Vries RP, Zhu X, McBride R, Rigter A, Hanson A, Zhong G, Hatta M, Xu R, Yu W, Kawaoka Y, de Haan CA, Wilson IA, Paulson JC. Hemagglutinin receptor specificity and structural analyses of respiratory droplet-transmissible H5N1 viruses. Journal of Virology. 88: 768-73. PMID 24173215 DOI: 10.1128/Jvi.02690-13 |
0.449 |
|
| 2014 |
Saphire EO, Bornholdt ZA, Abelson DM, Halfmann P, Noda T, Wood M, Kawaoka Y. Structural Rearrangement of the Ebola Virus VP40 Protein Begets Multiple Functions in the Virus Life Cycle Biophysical Journal. 106: 637a. DOI: 10.1016/J.Bpj.2013.11.3524 |
0.498 |
|
| 2014 |
Kawaoka Y, Neumann G. Reverse genetics approaches for rational design of inactivated and live attenuated influenza vaccines Novel Technologies For Vaccine Development. 3-32. DOI: 10.1007/978-3-7091-1818-4_1 |
0.415 |
|
| 2013 |
Ozawa M, Kawaoka Y. Cross talk between animal and human influenza viruses. Annual Review of Animal Biosciences. 1: 21-42. PMID 25387011 DOI: 10.1146/Annurev-Animal-031412-103733 |
0.655 |
|
| 2013 |
Watanabe T, Watanabe S, Kawaoka Y. [Cutting-edge of medicine; pandemic potential of H5N1 influenza virus]. Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine. 102: 2705-13. PMID 24400555 DOI: 10.2169/Naika.102.2705 |
0.654 |
|
| 2013 |
Nakayama M, Shichinohe S, Itoh Y, Ishigaki H, Kitano M, Arikata M, Pham VL, Ishida H, Kitagawa N, Okamatsu M, Sakoda Y, Ichikawa T, Tsuchiya H, Nakamura S, Le QM, ... ... Kawaoka Y, et al. Protection against H5N1 highly pathogenic avian and pandemic (H1N1) 2009 influenza virus infection in cynomolgus monkeys by an inactivated H5N1 whole particle vaccine. Plos One. 8: e82740. PMID 24376571 DOI: 10.1371/Journal.Pone.0082740 |
0.638 |
|
| 2013 |
Wilker PR, Dinis JM, Starrett G, Imai M, Hatta M, Nelson CW, O'Connor DH, Hughes AL, Neumann G, Kawaoka Y, Friedrich TC. Selection on haemagglutinin imposes a bottleneck during mammalian transmission of reassortant H5N1 influenza viruses. Nature Communications. 4: 2636. PMID 24149915 DOI: 10.1038/Ncomms3636 |
0.66 |
|
| 2013 |
Kobayashi H, Iwatsuki-Horimoto K, Kiso M, Uraki R, Ichiko Y, Takimoto T, Kawaoka Y. A replication-incompetent influenza virus bearing the HN glycoprotein of human parainfluenza virus as a bivalent vaccine. Vaccine. 31: 6239-46. PMID 24144478 DOI: 10.1016/J.Vaccine.2013.10.029 |
0.668 |
|
| 2013 |
Hill-Batorski L, Halfmann P, Neumann G, Kawaoka Y. The cytoprotective enzyme heme oxygenase-1 suppresses Ebola virus replication. Journal of Virology. 87: 13795-802. PMID 24109237 DOI: 10.1128/Jvi.02422-13 |
0.547 |
|
| 2013 |
Matsuoka Y, Matsumae H, Katoh M, Eisfeld AJ, Neumann G, Hase T, Ghosh S, Shoemaker JE, Lopes TJ, Watanabe T, Watanabe S, Fukuyama S, Kitano H, Kawaoka Y. A comprehensive map of the influenza A virus replication cycle. Bmc Systems Biology. 7: 97. PMID 24088197 DOI: 10.1186/1752-0509-7-97 |
0.634 |
|
| 2013 |
Sugita Y, Sagara H, Noda T, Kawaoka Y. Configuration of viral ribonucleoprotein complexes within the influenza A virion. Journal of Virology. 87: 12879-84. PMID 24067952 DOI: 10.1128/Jvi.02096-13 |
0.54 |
|
| 2013 |
Imai M, Herfst S, Sorrell EM, Schrauwen EJA, Linster M, De Graaf M, Fouchier RAM, Kawaoka Y. Transmission of influenza A/H5N1 viruses in mammals Virus Research. 178: 15-20. PMID 23954580 DOI: 10.1016/J.Virusres.2013.07.017 |
0.655 |
|
| 2013 |
Bornholdt ZA, Noda T, Abelson DM, Halfmann P, Wood MR, Kawaoka Y, Saphire EO. Structural rearrangement of ebola virus VP40 begets multiple functions in the virus life cycle. Cell. 154: 763-74. PMID 23953110 DOI: 10.1016/J.Cell.2013.07.015 |
0.48 |
|
| 2013 |
Mitchell HD, Eisfeld AJ, Sims AC, McDermott JE, Matzke MM, Webb-Robertson BJ, Tilton SC, Tchitchek N, Josset L, Li C, Ellis AL, Chang JH, Heegel RA, Luna ML, Schepmoes AA, ... ... Kawaoka Y, et al. A network integration approach to predict conserved regulators related to pathogenicity of influenza and SARS-CoV respiratory viruses. Plos One. 8: e69374. PMID 23935999 DOI: 10.1371/Journal.Pone.0069374 |
0.565 |
|
| 2013 |
Fouchier RA, Kawaoka Y, Cardona C, Compans RW, GarcÃa-Sastre A, Govorkova EA, Guan Y, Herfst S, Orenstein WA, Peiris JS, Perez DR, Richt JA, Russell C, Schultz-Cherry SL, Smith DJ, et al. Gain-of-function experiments on H7N9. Science (New York, N.Y.). 341: 612-3. PMID 23929965 DOI: 10.1126/science.341.6146.612 |
0.306 |
|
| 2013 |
Goto H, Muramoto Y, Noda T, Kawaoka Y. The genome-packaging signal of the influenza A virus genome comprises a genome incorporation signal and a genome-bundling signal. Journal of Virology. 87: 11316-22. PMID 23926345 DOI: 10.1128/Jvi.01301-13 |
0.405 |
|
| 2013 |
Fouchier RA, Kawaoka Y, Cardona C, Compans RW, García-Sastre A, Govorkova EA, Guan Y, Herfst S, Orenstein WA, Peiris JS, Perez DR, Richt JA, Russell C, Schultz-Cherry SL, Smith DJ, et al. Gain-of-Function Experiments on H7N9. Science (New York, N.Y.). PMID 23926190 DOI: 10.1126/Science.1243325 |
0.656 |
|
| 2013 |
Fouchier RA, Kawaoka Y, Cardona C, Compans RW, Fouchier RA, GarcÃa-Sastre A, Govorkova EA, Guan Y, Herfst S, Kawaoka Y, Orenstein WA, Peiris JS, Perez DR, Richt JA, Russell C, et al. Avian flu: Gain-of-function experiments on H7N9. Nature. 500: 150-1. PMID 23925229 DOI: 10.1038/500150A |
0.476 |
|
| 2013 |
Tchitchek N, Eisfeld AJ, Tisoncik-Go J, Josset L, Gralinski LE, Bécavin C, Tilton SC, Webb-Robertson BJ, Ferris MT, Totura AL, Li C, Neumann G, Metz TO, Smith RD, Waters KM, ... ... Kawaoka Y, et al. Specific mutations in H5N1 mainly impact the magnitude and velocity of the host response in mice. Bmc Systems Biology. 7: 69. PMID 23895213 DOI: 10.1186/1752-0509-7-69 |
0.543 |
|
| 2013 |
Watanabe T, Kiso M, Fukuyama S, Nakajima N, Imai M, Yamada S, Murakami S, Yamayoshi S, Iwatsuki-Horimoto K, Sakoda Y, Takashita E, McBride R, Noda T, Hatta M, Imai H, ... ... Kawaoka Y, et al. Characterization of H7N9 influenza A viruses isolated from humans. Nature. 501: 551-5. PMID 23842494 DOI: 10.1038/Nature12392 |
0.676 |
|
| 2013 |
Deng G, Tan D, Shi J, Cui P, Jiang Y, Liu L, Tian G, Kawaoka Y, Li C, Chen H. Complex reassortment of multiple subtypes of avian influenza viruses in domestic ducks at the Dongting Lake Region of China. Journal of Virology. 87: 9452-62. PMID 23804642 DOI: 10.1128/Jvi.00776-13 |
0.529 |
|
| 2013 |
Takahashi T, Song J, Suzuki T, Kawaoka Y. Mutations in NA that induced low pH-stability and enhanced the replication of pandemic (H1N1) 2009 influenza A virus at an early stage of the pandemic. Plos One. 8: e64439. PMID 23696893 DOI: 10.1371/Journal.Pone.0064439 |
0.612 |
|
| 2013 |
Takahashi K, Halfmann P, Oyama M, Kozuka-Hata H, Noda T, Kawaoka Y. DNA topoisomerase 1 facilitates the transcription and replication of the Ebola virus genome. Journal of Virology. 87: 8862-9. PMID 23658456 DOI: 10.1128/Jvi.03544-12 |
0.44 |
|
| 2013 |
Uraki R, Kiso M, Iwatsuki-Horimoto K, Fukuyama S, Takashita E, Ozawa M, Kawaoka Y. A novel bivalent vaccine based on a PB2-knockout influenza virus protects mice from pandemic H1N1 and highly pathogenic H5N1 virus challenges. Journal of Virology. 87: 7874-81. PMID 23658445 DOI: 10.1128/Jvi.00076-13 |
0.628 |
|
| 2013 |
Xiong X, Coombs PJ, Martin SR, Liu J, Xiao H, McCauley JW, Locher K, Walker PA, Collins PJ, Kawaoka Y, Skehel JJ, Gamblin SJ. Receptor binding by a ferret-transmissible H5 avian influenza virus. Nature. 497: 392-6. PMID 23615615 DOI: 10.1038/Nature12144 |
0.534 |
|
| 2013 |
Kageyama T, Fujisaki S, Takashita E, Xu H, Yamada S, Uchida Y, Neumann G, Saito T, Kawaoka Y, Tashiro M. Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013. Euro Surveillance : Bulletin Europã©En Sur Les Maladies Transmissibles = European Communicable Disease Bulletin. 18: 20453. PMID 23594575 DOI: 10.2807/Ese.18.15.20453-En |
0.661 |
|
| 2013 |
Kiso M, Takano R, Sakabe S, Katsura H, Shinya K, Uraki R, Watanabe S, Saito H, Toba M, Kohda N, Kawaoka Y. Protective efficacy of orally administered, heat-killed Lactobacillus pentosus b240 against influenza A virus. Scientific Reports. 3: 1563. PMID 23535544 DOI: 10.1038/Srep01563 |
0.544 |
|
| 2013 |
Morita M, Kuba K, Ichikawa A, Nakayama M, Katahira J, Iwamoto R, Watanebe T, Sakabe S, Daidoji T, Nakamura S, Kadowaki A, Ohto T, Nakanishi H, Taguchi R, Nakaya T, ... ... Kawaoka Y, et al. The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell. 153: 112-25. PMID 23477864 DOI: 10.1016/J.Cell.2013.02.027 |
0.587 |
|
| 2013 |
Watanabe T, Tisoncik-Go J, Tchitchek N, Watanabe S, Benecke AG, Katze MG, Kawaoka Y. 1918 Influenza virus hemagglutinin (HA) and the viral RNA polymerase complex enhance viral pathogenicity, but only HA induces aberrant host responses in mice. Journal of Virology. 87: 5239-54. PMID 23449804 DOI: 10.1128/Jvi.02753-12 |
0.667 |
|
| 2013 |
Fan S, Macken CA, Li C, Ozawa M, Goto H, Iswahyudi NF, Nidom CA, Chen H, Neumann G, Kawaoka Y. Synergistic effect of the PDZ and p85β-binding domains of the NS1 protein on virulence of an avian H5N1 influenza A virus. Journal of Virology. 87: 4861-71. PMID 23408626 DOI: 10.1128/Jvi.02608-12 |
0.597 |
|
| 2013 |
Nanbo A, Watanabe S, Halfmann P, Kawaoka Y. The spatio-temporal distribution dynamics of Ebola virus proteins and RNA in infected cells. Scientific Reports. 3: 1206. PMID 23383374 DOI: 10.1038/Srep01206 |
0.443 |
|
| 2013 |
Fouchier RA, García-Sastre A, Kawaoka Y. H5N1 virus: Transmission studies resume for avian flu. Nature. 493: 609. PMID 23354044 DOI: 10.1038/Nature11858 |
0.668 |
|
| 2013 |
Ozawa M, Shimojima M, Goto H, Watanabe S, Hatta Y, Kiso M, Furuta Y, Horimoto T, Peters NR, Hoffmann FM, Kawaoka Y. A cell-based screening system for influenza A viral RNA transcription/replication inhibitors. Scientific Reports. 3: 1106. PMID 23346363 DOI: 10.1038/Srep01106 |
0.545 |
|
| 2013 |
Fouchier RA, GarcÃa-Sastre A, Kawaoka Y, Barclay WS, Bouvier NM, Brown IH, Capua I, Chen H, Compans RW, Couch RB, Cox NJ, Doherty PC, Donis RO, Feldmann H, Guan Y, et al. Transmission studies resume for avian flu. Science (New York, N.Y.). 339: 520-1. PMID 23345603 DOI: 10.1126/Science.1235140 |
0.519 |
|
| 2013 |
Van Kerkhove MD, Hirve S, Koukounari A, Mounts AW, Allwinn R, Bandaranayake DD, Bella AA, Bone A, Carrat F, Chadha MS, Chen M, Chi CY, Cox CMCM, Cretikos M, Crowcroft N, ... ... Kawaoka Y, et al. Estimating age-specific cumulative incidence for the 2009 influenza pandemic: A meta-analysis of A(H1N1)pdm09 serological studies from 19 countries Influenza and Other Respiratory Viruses. 7: 872-886. PMID 23331969 DOI: 10.1111/irv.12074 |
0.49 |
|
| 2013 |
Marzi A, Engelmann F, Feldmann F, Haberthur K, Shupert WL, Brining D, Scott DP, Geisbert TW, Kawaoka Y, Katze MG, Feldmann H, Messaoudi I. Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates. Proceedings of the National Academy of Sciences of the United States of America. 110: 1893-8. PMID 23319647 DOI: 10.1073/Pnas.1209591110 |
0.406 |
|
| 2013 |
Schaefer MH, Lopes TJ, Mah N, Shoemaker JE, Matsuoka Y, Fontaine JF, Louis-Jeune C, Eisfeld AJ, Neumann G, Perez-Iratxeta C, Kawaoka Y, Kitano H, Andrade-Navarro MA. Adding protein context to the human protein-protein interaction network to reveal meaningful interactions. Plos Computational Biology. 9: e1002860. PMID 23300433 DOI: 10.1371/Journal.Pcbi.1002860 |
0.352 |
|
| 2013 |
Fehling SK, Noda T, Maisner A, Lamp B, Conzelmann KK, Kawaoka Y, Klenk HD, Garten W, Strecker T. The microtubule motor protein KIF13A is involved in intracellular trafficking of the Lassa virus matrix protein Z. Cellular Microbiology. 15: 315-34. PMID 23279019 DOI: 10.1111/Cmi.12095 |
0.381 |
|
| 2013 |
Gen F, Yamada S, Kato K, Akashi H, Kawaoka Y, Horimoto T. Attenuation of an influenza A virus due to alteration of its hemagglutinin-neuraminidase functional balance in mice. Archives of Virology. 158: 1003-11. PMID 23247916 DOI: 10.1007/S00705-012-1577-3 |
0.638 |
|
| 2013 |
Muramoto Y, Noda T, Kawakami E, Akkina R, Kawaoka Y. Identification of novel influenza A virus proteins translated from PA mRNA. Journal of Virology. 87: 2455-62. PMID 23236060 DOI: 10.1128/Jvi.02656-12 |
0.63 |
|
| 2013 |
Uraki R, Kiso M, Shinya K, Goto H, Takano R, Iwatsuki-Horimoto K, Takahashi K, Daniels RS, Hungnes O, Watanabe T, Kawaoka Y. Virulence determinants of pandemic A(H1N1)2009 influenza virus in a mouse model. Journal of Virology. 87: 2226-33. PMID 23221570 DOI: 10.1128/Jvi.01565-12 |
0.685 |
|
| 2013 |
Ichikawa A, Kuba K, Morita M, Chida S, Tezuka H, Hara H, Sasaki T, Ohteki T, Ranieri VM, dos Santos CC, Kawaoka Y, Akira S, Luster AD, Lu B, Penninger JM, et al. CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin. American Journal of Respiratory and Critical Care Medicine. 187: 65-77. PMID 23144331 DOI: 10.1164/Rccm.201203-0508Oc |
0.505 |
|
| 2013 |
Takano R, Kiso M, Igarashi M, Le QM, Sekijima M, Ito K, Takada A, Kawaoka Y. Molecular mechanisms underlying oseltamivir resistance mediated by an I117V substitution in the neuraminidase of subtype H5N1 avian influenza a viruses Journal of Infectious Diseases. 207: 89-97. PMID 23053629 DOI: 10.1093/Infdis/Jis633 |
0.619 |
|
| 2013 |
Ebihara H, Zivcec M, Gardner D, Falzarano D, LaCasse R, Rosenke R, Long D, Haddock E, Fischer E, Kawaoka Y, Feldmann H. A Syrian golden hamster model recapitulating ebola hemorrhagic fever. The Journal of Infectious Diseases. 207: 306-18. PMID 23045629 DOI: 10.1093/Infdis/Jis626 |
0.405 |
|
| 2013 |
Sakabe S, Takano R, Nagamura-Inoue T, Yamashita N, Nidom CA, Quynh Le MT, Iwatsuki-Horimoto K, Kawaoka Y. Differences in cytokine production in human macrophages and in virulence in mice are attributable to the acidic polymerase protein of highly pathogenic influenza A virus subtype H5N1 Journal of Infectious Diseases. 207: 262-271. PMID 23042757 DOI: 10.1093/Infdis/Jis523 |
0.594 |
|
| 2012 |
Takahashi T, Nidom CA, Quynh Le MT, Suzuki T, Kawaoka Y. Amino acid determinants conferring stable sialidase activity at low pH for H5N1 influenza A virus neuraminidase. Febs Open Bio. 2: 261-6. PMID 23650608 DOI: 10.1016/j.fob.2012.08.007 |
0.497 |
|
| 2012 |
Neumann G, Macken CA, Karasin AI, Fouchier RA, Kawaoka Y. Egyptian H5N1 influenza viruses-cause for concern? Plos Pathogens. 8: e1002932. PMID 23166487 DOI: 10.1371/Journal.Ppat.1002932 |
0.678 |
|
| 2012 |
Fouchier RAM, García-Sastre A, Kawaoka Y. The pause on avian H5N1 influenza virus transmission research should be ended Mbio. 3. PMID 23047750 DOI: 10.1128/Mbio.00358-12 |
0.587 |
|
| 2012 |
Kajihara M, Marzi A, Nakayama E, Noda T, Kuroda M, Manzoor R, Matsuno K, Feldmann H, Yoshida R, Kawaoka Y, Takada A. Inhibition of marburg virus budding by nonneutralizing antibodiesto the envelope glycoprotein Journal of Virology. 86: 13467-13474. PMID 23035224 DOI: 10.1128/Jvi.01896-12 |
0.481 |
|
| 2012 |
Bale S, Julien JP, Bornholdt ZA, Kimberlin CR, Halfmann P, Zandonatti MA, Kunert J, Kroon GJ, Kawaoka Y, MacRae IJ, Wilson IA, Saphire EO. Marburg virus VP35 can both fully coat the backbone and cap the ends of dsRNA for interferon antagonism. Plos Pathogens. 8: e1002916. PMID 23028316 DOI: 10.1371/Journal.Ppat.1002916 |
0.428 |
|
| 2012 |
Takashita E, Muraki Y, Sugawara K, Asao H, Nishimura H, Suzuki K, Tsuji T, Hongo S, Ohara Y, Ohara Y, Kawaoka Y, Ozawa M, Matsuzaki Y. Intrinsic temperature sensitivity of influenza C virus hemagglutinin-esterase-fusion protein. Journal of Virology. 86: 13108-11. PMID 23015703 DOI: 10.1128/Jvi.01925-12 |
0.534 |
|
| 2012 |
Das SC, Hatta M, Wilker PR, Myc A, Hamouda T, Neumann G, Baker JR, Kawaoka Y. Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccine. Vaccine. 30: 6871-7. PMID 22989689 DOI: 10.1016/J.Vaccine.2012.09.007 |
0.426 |
|
| 2012 |
Shoemaker JE, Fukuyama S, Eisfeld AJ, Muramoto Y, Watanabe S, Watanabe T, Matsuoka Y, Kitano H, Kawaoka Y. Integrated network analysis reveals a novel role for the cell cycle in 2009 pandemic influenza virus-induced inflammation in macaque lungs. Bmc Systems Biology. 6: 117. PMID 22937776 DOI: 10.1186/1752-0509-6-117 |
0.686 |
|
| 2012 |
Kingstad-Bakke B, Brewoo JN, Mai LQ, Kawaoka Y, Osorio JE. Effects of route and coadministration of recombinant raccoon poxviruses on immune responses and protection against highly pathogenic avian influenza in mice Vaccine. 30: 6402-6408. PMID 22921740 DOI: 10.1016/J.Vaccine.2012.08.018 |
0.603 |
|
| 2012 |
Ilyushina NA, Ikizler MR, Kawaoka Y, Rudenko LG, Treanor JJ, Subbarao K, Wright PF. Comparative study of influenza virus replication in MDCK cells and in primary cells derived from adenoids and airway epithelium. Journal of Virology. 86: 11725-34. PMID 22915797 DOI: 10.1128/Jvi.01477-12 |
0.612 |
|
| 2012 |
Imai M, Watanabe S, Kawaoka Y. The cytoplasmic tail domain of influenza B virus hemagglutinin is important for its incorporation into virions but is not essential for virus replication in cell culture in the presence of compensatory mutations Journal of Virology. 86: 11633-11644. PMID 22896616 DOI: 10.1128/Jvi.01479-12 |
0.631 |
|
| 2012 |
Katsura H, Iwatsuki-Horimoto K, Fukuyama S, Watanabe S, Sakabe S, Hatta Y, Murakami S, Shimojima M, Horimoto T, Kawaoka Y. A replication-incompetent virus possessing an uncleavable hemagglutinin as an influenza vaccine. Vaccine. 30: 6027-33. PMID 22867723 DOI: 10.1016/J.Vaccine.2012.07.059 |
0.667 |
|
| 2012 |
Inagaki A, Goto H, Kakugawa S, Ozawa M, Kawaoka Y. Competitive incorporation of homologous gene segments of influenza A virus into virions Journal of Virology. 86: 10200-10202. PMID 22740412 DOI: 10.1128/Jvi.01204-12 |
0.557 |
|
| 2012 |
Zhang Y, Zhang Q, Gao Y, He X, Kong H, Jiang Y, Guan Y, Xia X, Shu Y, Kawaoka Y, Bu Z, Chen H. Key molecular factors in hemagglutinin and PB2 contribute to efficient transmission of the 2009 H1N1 pandemic influenza virus. Journal of Virology. 86: 9666-74. PMID 22740390 DOI: 10.1128/Jvi.00958-12 |
0.675 |
|
| 2012 |
Russell CA, Fonville JM, Brown AE, Burke DF, Smith DL, James SL, Herfst S, van Boheemen S, Linster M, Schrauwen EJ, Katzelnick L, MosterÃn A, Kuiken T, Maher E, Neumann G, ... ... Kawaoka Y, et al. The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science (New York, N.Y.). 336: 1541-7. PMID 22723414 DOI: 10.1126/Science.1222526 |
0.67 |
|
| 2012 |
Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, Zhong G, Hanson A, Katsura H, Watanabe S, Li C, Kawakami E, Yamada S, Kiso M, Suzuki Y, ... ... Kawaoka Y, et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets Nature. 486: 420-428. PMID 22722205 DOI: 10.1038/Nature10831 |
0.665 |
|
| 2012 |
Watanabe T, Imai M, Watanabe S, Shinya K, Hatta M, Li C, Neumann G, Ozawa M, Hanson A, Zhong G, Fukuyama S, Kawakami E, Simmons HA, Schenkman D, Brunner K, ... ... Kawaoka Y, et al. Characterization in vitro and in vivo of pandemic (H1N1) 2009 influenza viruses isolated from patients. Journal of Virology. 86: 9361-8. PMID 22718834 DOI: 10.1128/Jvi.01214-12 |
0.621 |
|
| 2012 |
Shimojima M, Kawaoka Y. Cell surface molecules involved in infection mediated by lymphocytic choriomeningitis virus glycoprotein Journal of Veterinary Medical Science. 74: 1363-1366. PMID 22673088 DOI: 10.1292/Jvms.12-0176 |
0.44 |
|
| 2012 |
Chu C, Fan S, Li C, Macken C, Kim JH, Hatta M, Neumann G, Kawaoka Y. Functional analysis of conserved motifs in influenza virus PB1 protein. Plos One. 7: e36113. PMID 22615752 DOI: 10.1371/Journal.Pone.0036113 |
0.608 |
|
| 2012 |
Noda T, Kawaoka Y. Packaging of influenza virus genome: Robustness of selection Proceedings of the National Academy of Sciences of the United States of America. 109: 8797-8798. PMID 22615368 DOI: 10.1073/Pnas.1206736109 |
0.584 |
|
| 2012 |
Neumann G, Ozawa M, Kawaoka Y. Reverse genetics of influenza viruses Methods in Molecular Biology. 865: 193-206. PMID 22528161 DOI: 10.1007/978-1-61779-621-0_12 |
0.634 |
|
| 2012 |
Kawaoka Y, Neumann G. Influenza viruses: an introduction. Methods in Molecular Biology (Clifton, N.J.). 865: 1-9. PMID 22528150 DOI: 10.1007/978-1-61779-621-0_1 |
0.584 |
|
| 2012 |
Kawaoka Y, Neumann G. Influenza viruses: an introduction. Methods in Molecular Biology (Clifton, N.J.). 865: 1-9. PMID 22528150 DOI: 10.1007/978-1-61779-621-0_1 |
0.584 |
|
| 2012 |
Kikuchi T, Iwatsuki-Horimoto K, Adachi E, Koga M, Nakamura H, Hosoya N, Kawana-Tachikawa A, Koibuchi T, Miura T, Fujii T, Kawaoka Y, Iwamoto A. Improved neutralizing antibody response in the second season after a single dose of pandemic (H1N1) 2009 influenza vaccine in HIV-1-positive adults. Vaccine. 30: 3819-23. PMID 22504038 DOI: 10.1016/J.Vaccine.2012.03.083 |
0.395 |
|
| 2012 |
Shinya K, Gao Y, Cilloniz C, Suzuki Y, Fujie M, Deng G, Zhu Q, Fan S, Makino A, Muramoto Y, Fukuyama S, Tamura D, Noda T, Eisfeld AJ, Katze MG, ... ... Kawaoka Y, et al. Integrated clinical, pathologic, virologic, and transcriptomic analysis of H5N1 influenza virus-induced viral pneumonia in the rhesus macaque. Journal of Virology. 86: 6055-66. PMID 22491448 DOI: 10.1128/Jvi.00365-12 |
0.642 |
|
| 2012 |
Imai M, Kawaoka Y. The role of receptor binding specificity in interspecies transmission of influenza viruses Current Opinion in Virology. 2: 160-167. PMID 22445963 DOI: 10.1016/J.Coviro.2012.03.003 |
0.633 |
|
| 2012 |
Gorai T, Goto H, Noda T, Watanabe T, Kozuka-Hata H, Oyama M, Takano R, Neumann G, Watanabe S, Kawaoka Y. F1Fo-ATPase, F-type proton-translocating ATPase, at the plasma membrane is critical for efficient influenza virus budding Proceedings of the National Academy of Sciences of the United States of America. 109: 4615-4620. PMID 22393008 DOI: 10.1073/Pnas.1114728109 |
0.604 |
|
| 2012 |
Bharat TA, Noda T, Riches JD, Kraehling V, Kolesnikova L, Becker S, Kawaoka Y, Briggs JA. Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography. Proceedings of the National Academy of Sciences of the United States of America. 109: 4275-80. PMID 22371572 DOI: 10.1073/Pnas.1120453109 |
0.548 |
|
| 2012 |
Nidom CA, Yamada S, Nidom RV, Rahmawati K, Alamudi MY, Kholik, Indrasari S, Hayati RS, Iwatsuki Horimoto K, Kawaoka Y. Genetic characterization of H5N1 influenza viruses isolated from chickens in Indonesia in 2010 Virus Genes. 44: 459-465. PMID 22323117 DOI: 10.1007/S11262-012-0722-0 |
0.655 |
|
| 2012 |
Victor ST, Watanabe S, Katsura H, Ozawa M, Kawaoka Y. A replication-incompetent PB2-knockout influenza a virus vaccine vector Journal of Virology. 86: 4123-4128. PMID 22301144 DOI: 10.1128/Jvi.06232-11 |
0.654 |
|
| 2012 |
Kawai Y, Kimura Y, Lezhava A, Kanamori H, Usui K, Hanami T, Soma T, Morlighem JÉ, Saga S, Ishizu Y, Aoki S, Endo R, Oguchi-Katayama A, Kogo Y, Mitani Y, ... ... Kawaoka Y, et al. One-step detection of the 2009 pandemic influenza A(H1N1) virus by the RT-SmartAmp assay and its clinical validation. Plos One. 7: e30236. PMID 22295077 DOI: 10.1371/Journal.Pone.0030236 |
0.654 |
|
| 2012 |
Fouchier RA, GarcÃa-Sastre A, Kawaoka Y, Barclay WS, Bouvier NM, Brown IH, Capua I, Chen H, Compans RW, Couch RB, Cox NJ, Doherty PC, Donis RO, Feldmann H, Guan Y, et al. Pause on avian flu transmission research. Science (New York, N.Y.). 335: 400-1. PMID 22282787 DOI: 10.1126/science.335.6067.400 |
0.635 |
|
| 2012 |
Shi J, Wen Z, Guo J, Zhang Y, Deng G, Shu Y, Wang D, Jiang Y, Kawaoka Y, Bu Z, Chen H. Protective efficacy of an H1N1 cold-adapted live vaccine against the 2009 pandemic H1N1, seasonal H1N1, and H5N1 influenza viruses in mice Antiviral Research. 93: 346-353. PMID 22281419 DOI: 10.1016/J.Antiviral.2012.01.001 |
0.677 |
|
| 2012 |
Kawaoka Y. H5N1: Flu transmission work is urgent Nature. 482: 155. PMID 22278057 DOI: 10.1038/Nature10884 |
0.533 |
|
| 2012 |
Noda T, Sugita Y, Aoyama K, Hirase A, Kawakami E, Miyazawa A, Sagara H, Kawaoka Y. Three-dimensional analysis of ribonucleoprotein complexes in influenza A virus. Nature Communications. 3: 639. PMID 22273677 DOI: 10.1038/Ncomms1647 |
0.503 |
|
| 2012 |
Fouchier RAM, García-Sastre A, Kawaoka Y. Pause on avian flu transmission studies Nature. 481: 443. PMID 22266939 DOI: 10.1038/481443A |
0.41 |
|
| 2012 |
Olal D, Kuehne AI, Bale S, Halfmann P, Hashiguchi T, Fusco ML, Lee JE, King LB, Kawaoka Y, Dye JM, Saphire EO. Structure of an antibody in complex with its mucin domain linear epitope that is protective against Ebola virus. Journal of Virology. 86: 2809-16. PMID 22171276 DOI: 10.1128/Jvi.05549-11 |
0.458 |
|
| 2012 |
Shimojima M, Ströher U, Ebihara H, Feldmann H, Kawaoka Y. Identification of cell surface molecules involved in dystroglycan-independent Lassa virus cell entry Journal of Virology. 86: 2067-2078. PMID 22156524 DOI: 10.1128/Jvi.06451-11 |
0.474 |
|
| 2012 |
Das SC, Watanabe S, Hatta M, Noda T, Neumann G, Ozawa M, Kawaoka Y. The Highly Conserved Arginine Residues at Positions 76 through 78 of Influenza A Virus Matrix Protein M1 Play an Important Role in Viral Replication by Affecting the Intracellular Localization of M1 Journal of Virology. 86: 1522-1530. PMID 22090133 DOI: 10.1128/Jvi.06230-11 |
0.583 |
|
| 2012 |
Murakami S, Horimoto T, Ito M, Takano R, Katsura H, Shimojima M, Kawaoka Y. Enhanced growth of influenza vaccine seed viruses in vero cells mediated by broadening the optimal pH range for virus membrane fusion. Journal of Virology. 86: 1405-10. PMID 22090129 DOI: 10.1128/Jvi.06009-11 |
0.511 |
|
| 2012 |
Yamada S, Shinya K, Takada A, Ito T, Suzuki T, Suzuki Y, Le QM, Ebina M, Kasai N, Kida H, Horimoto T, Rivailler P, Chen LM, Donis RO, Kawaoka Y. Adaptation of a duck influenza A virus in quail. Journal of Virology. 86: 1411-20. PMID 22090115 DOI: 10.1128/Jvi.06100-11 |
0.672 |
|
| 2012 |
Shinya K, Ito M, Makino A, Tanaka M, Miyake K, Eisfeld AJ, Kawaoka Y. The TLR4-TRIF pathway protects against H5N1 influenza virus infection Journal of Virology. 86: 19-24. PMID 22031950 DOI: 10.1128/Jvi.06168-11 |
0.532 |
|
| 2012 |
Ginting TE, Shinya K, Kyan Y, Makino A, Matsumoto N, Kaneda S, Kawaoka Y. Amino acid changes in hemagglutinin contribute to the replication of oseltamivir-resistant H1N1 influenza viruses Journal of Virology. 86: 121-127. PMID 22013054 DOI: 10.1128/Jvi.06085-11 |
0.531 |
|
| 2012 |
Olal D, Kuehne A, Bale S, Halfmann P, Hashiguchi T, Fusco ML, Lee JE, King LB, Kawaoka Y, Dye JM, Saphire EO. Structure of an Ebola Virus-Protective Antibody in Complex with its Mucin-Domain Linear Epitope. Journal of Virology. 86: 2809. DOI: 10.2210/Pdb2Y6S/Pdb |
0.43 |
|
| 2012 |
Takahashi T, Nidom CA, Quynh Le Mt, Suzuki T, Kawaoka Y. Amino acid determinants conferring stable sialidase activity at low pH for H5N1 influenza A virus neuraminidase Febs Open Bio. 2: 261-266. DOI: 10.1016/J.Fob.2012.08.007 |
0.58 |
|
| 2012 |
Menachery V, Sims A, Eisfeld A, Gralinski L, Chang J, Waters K, Metz T, Kawaoka Y, Katze M, Baric R. P115 Pathogenic Influenza A viruses and SARS-Coronaviruses modulate global interferon stimulated gene induction through diverse mechanisms Cytokine. 59: 556. DOI: 10.1016/J.Cyto.2012.06.206 |
0.607 |
|
| 2011 |
Tanaka M, Tsumura K, Ito H, Ito T, Ono E, Makino A, Kawaoka Y, Shinya K. Characteristics of influenza virus genome mutations Kobe Journal of Medical Sciences. 57: E116-E127. PMID 22971946 |
0.574 |
|
| 2011 |
Weinfurter JT, Brunner K, Capuano SV, Li C, Broman KW, Kawaoka Y, Friedrich TC. Cross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates. Plos Pathogens. 7: e1002381. PMID 22102819 DOI: 10.1371/Journal.Ppat.1002381 |
0.554 |
|
| 2011 |
Dias JM, Kuehne AI, Abelson DM, Bale S, Wong AC, Halfmann P, Muhammad MA, Fusco ML, Zak SE, Kang E, Kawaoka Y, Chandran K, Dye JM, Saphire EO. A shared structural solution for neutralizing ebolaviruses. Nature Structural & Molecular Biology. 18: 1424-7. PMID 22101933 DOI: 10.1038/Nsmb.2150 |
0.406 |
|
| 2011 |
Peng X, Gralinski L, Ferris MT, Frieman MB, Thomas MJ, Proll S, Korth MJ, Tisoncik JR, Heise M, Luo S, Schroth GP, Tumpey TM, Li C, Kawaoka Y, Baric RS, et al. Integrative deep sequencing of the mouse lung transcriptome reveals differential expression of diverse classes of small RNAs in response to respiratory virus infection. Mbio. 2. PMID 22086488 DOI: 10.1128/Mbio.00198-11 |
0.46 |
|
| 2011 |
McDermott JE, Shankaran H, Eisfeld AJ, Belisle SE, Neuman G, Li C, McWeeney S, Sabourin C, Kawaoka Y, Katze MG, Waters KM. Conserved host response to highly pathogenic avian influenza virus infection in human cell culture, mouse and macaque model systems. Bmc Systems Biology. 5: 190. PMID 22074594 DOI: 10.1186/1752-0509-5-190 |
0.529 |
|
| 2011 |
Garulli B, Di Mario G, Sciaraffia E, Kawaoka Y, Castrucci MR. Immunogenicity of a recombinant influenza virus bearing both the CD4+ and CD8+ T cell epitopes of ovalbumin Journal of Biomedicine and Biotechnology. 2011. PMID 22007143 DOI: 10.1155/2011/497364 |
0.433 |
|
| 2011 |
Iwasa A, Halfmann P, Noda T, Oyama M, Kozuka-Hata H, Watanabe S, Shimojima M, Watanabe T, Kawaoka Y. Contribution of sec61α to the life cycle of Ebola virus Journal of Infectious Diseases. 204: S919-S926. PMID 21987770 DOI: 10.1093/Infdis/Jir324 |
0.483 |
|
| 2011 |
Iwasa A, Shimojima M, Kawaoka Y. SGP serves as a structural protein in ebola virus infection Journal of Infectious Diseases. 204: S897-S903. PMID 21987767 DOI: 10.1093/Infdis/Jir313 |
0.384 |
|
| 2011 |
Noda T, Kolesnikova L, Becker S, Kawaoka Y. The importance of the NP: VP35 ratio in Ebola virus nucleocapsid formation Journal of Infectious Diseases. 204: S878-S883. PMID 21987764 DOI: 10.1093/Infdis/Jir310 |
0.42 |
|
| 2011 |
Makino A, Yamayoshi S, Shinya K, Noda T, Kawaoka Y. Identification of amino acids in marburg virus VP40 that are important for virus-like particle budding Journal of Infectious Diseases. 204: S871-S877. PMID 21987763 DOI: 10.1093/Infdis/Jir309 |
0.549 |
|
| 2011 |
Hatakeyama S, Iwatsuki-Horimoto K, Okamoto K, Nukui Y, Yata N, Fujita A, Inaba S, Yotsuyanagi H, Kawaoka Y. Unadjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected adults Vaccine. 29: 9224-9228. PMID 21978767 DOI: 10.1016/J.Vaccine.2011.09.106 |
0.404 |
|
| 2011 |
Ozawa M, Kawaoka Y. Taming influenza viruses Virus Research. 162: 8-11. PMID 21968297 DOI: 10.1016/J.Virusres.2011.09.035 |
0.65 |
|
| 2011 |
Watanabe T, Shinya K, Watanabe S, Imai M, Hatta M, Li C, Wolter BF, Neumann G, Hanson A, Ozawa M, Yamada S, Imai H, Sakabe S, Takano R, Iwatsuki-Horimoto K, ... ... Kawaoka Y, et al. Avian-type receptor-binding ability can increase influenza virus pathogenicity in macaques. Journal of Virology. 85: 13195-203. PMID 21937653 DOI: 10.1128/Jvi.00859-11 |
0.6 |
|
| 2011 |
Ozawa M, Victor ST, Taft AS, Yamada S, Li C, Hatta M, Das SC, Takashita E, Kakugawa S, Maher EA, Neumann G, Kawaoka Y. Replication-incompetent influenza A viruses that stably express a foreign gene Journal of General Virology. 92: 2879-2888. PMID 21880840 DOI: 10.1099/Vir.0.037648-0 |
0.647 |
|
| 2011 |
Li C, Bankhead A, Eisfeld AJ, Hatta Y, Jeng S, Chang JH, Aicher LD, Proll S, Ellis AL, Law GL, Waters KM, Neumann G, Katze MG, McWeeney S, Kawaoka Y. Host regulatory network response to infection with highly pathogenic H5N1 avian influenza virus. Journal of Virology. 85: 10955-67. PMID 21865398 DOI: 10.1128/Jvi.05792-11 |
0.642 |
|
| 2011 |
Liu J, Chen P, Jiang Y, Wu L, Zeng X, Tian G, Ge J, Kawaoka Y, Bu Z, Chen H. A duck enteritis virus-vectored bivalent live vaccine provides fast and complete protection against H5N1 avian influenza virus infection in ducks. Journal of Virology. 85: 10989-98. PMID 21865383 DOI: 10.1128/Jvi.05420-11 |
0.632 |
|
| 2011 |
Fukuyama S, Kawaoka Y. The pathogenesis of influenza virus infections: The contributions of virus and host factors Current Opinion in Immunology. 23: 481-486. PMID 21840185 DOI: 10.1016/J.Coi.2011.07.016 |
0.678 |
|
| 2011 |
Sugita Y, Noda T, Sagara H, Kawaoka Y. Ultracentrifugation deforms unfixed influenza A virions. The Journal of General Virology. 92: 2485-93. PMID 21795472 DOI: 10.1099/Vir.0.036715-0 |
0.598 |
|
| 2011 |
Eisfeld AJ, Neumann G, Kawaoka Y. Human immunodeficiency virus rev-binding protein is essential for influenza a virus replication and promotes genome trafficking in late-stage infection Journal of Virology. 85: 9588-9598. PMID 21752912 DOI: 10.1128/Jvi.05064-11 |
0.654 |
|
| 2011 |
Cilloniz C, Ebihara H, Ni C, Neumann G, Korth MJ, Kelly SM, Kawaoka Y, Feldmann H, Katze MG. Functional genomics reveals the induction of inflammatory response and metalloproteinase gene expression during lethal Ebola virus infection. Journal of Virology. 85: 9060-8. PMID 21734050 DOI: 10.1128/Jvi.00659-11 |
0.543 |
|
| 2011 |
Yan P, Zhao Y, Zhang X, Xu D, Dai X, Teng Q, Yan L, Zhou J, Ji X, Zhang S, Liu G, Zhou Y, Kawaoka Y, Tong G, Li Z. An infectious disease of ducks caused by a newly emerged Tembusu virus strain in mainland China. Virology. 417: 1-8. PMID 21722935 DOI: 10.1016/J.Virol.2011.06.003 |
0.603 |
|
| 2011 |
Walsh KB, Teijaro JR, Wilker PR, Jatzek A, Fremgen DM, Das SC, Watanabe T, Hatta M, Shinya K, Suresh M, Kawaoka Y, Rosen H, Oldstone MB. Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus. Proceedings of the National Academy of Sciences of the United States of America. 108: 12018-23. PMID 21715659 DOI: 10.1073/Pnas.1107024108 |
0.633 |
|
| 2011 |
Yamaoka M, Palilingan JF, Wibisono J, Yudhawati R, Nidom RV, Alamudi MY, Ginting TE, Makino A, Nidom CA, Shinya K, Kawaoka Y. Virological surveillance of human influenza in Indonesia, October 2008-March 2010 Microbiology and Immunology. 55: 514-517. PMID 21707740 DOI: 10.1111/J.1348-0421.2011.00344.X |
0.649 |
|
| 2011 |
Poetranto ED, Yamaoka M, Nastri AM, Krisna LA, Rahman MH, Wulandari L, Yudhawati R, Ginting TE, Makino A, Shinya K, Kawaoka Y. An H5N1 highly pathogenic avian influenza virus isolated from a local tree sparrow in Indonesia. Microbiology and Immunology. 55: 666-72. PMID 21699556 DOI: 10.1111/J.1348-0421.2011.00361.X |
0.652 |
|
| 2011 |
Octaviani CP, Goto H, Kawaoka Y. Reassortment between seasonal H1N1 and pandemic (H1N1) 2009 influenza viruses is restricted by limited compatibility among polymerase subunits Journal of Virology. 85: 8449-8452. PMID 21680507 DOI: 10.1128/Jvi.05054-11 |
0.675 |
|
| 2011 |
Morlighem JÉ, Aoki S, Kishima M, Hanami M, Ogawa C, Jalloh A, Takahashi Y, Kawai Y, Saga S, Hayashi E, Ban T, Izumi S, Wada A, Mano M, Fukunaga M, ... ... Kawaoka Y, et al. Mutation analysis of 2009 pandemic influenza A(H1N1) viruses collected in Japan during the peak phase of the pandemic. Plos One. 6: e18956. PMID 21572517 DOI: 10.1371/Journal.Pone.0018956 |
0.626 |
|
| 2011 |
Eisfeld AJ, Kawakami E, Watanabe T, Neumann G, Kawaoka Y. RAB11A is essential for transport of the influenza virus genome to the plasma membrane Journal of Virology. 85: 6117-6126. PMID 21525351 DOI: 10.1128/Jvi.00378-11 |
0.486 |
|
| 2011 |
Neumann G, Kawaoka Y. The first influenza pandemic of the new millennium Influenza and Other Respiratory Viruses. 5: 157-166. PMID 21477134 DOI: 10.1111/J.1750-2659.2011.00231.X |
0.677 |
|
| 2011 |
Shimizu K, Li C, Muramoto Y, Yamada S, Arikawa J, Chen H, Kawaoka Y. The nucleoprotein and matrix protein segments of H5N1 influenza viruses are responsible for dominance in embryonated eggs Journal of General Virology. 92: 1645-1649. PMID 21471324 DOI: 10.1099/Vir.0.030247-0 |
0.657 |
|
| 2011 |
Horimoto T, Maeda K, Murakami S, Kiso M, Iwatsuki-Horimoto K, Sashika M, Ito T, Suzuki K, Yokoyama M, Kawaoka Y. Highly pathogenic avian influenza virus infection in feral Raccoons, Japan Emerging Infectious Diseases. 17: 714-717. PMID 21470469 DOI: 10.3201/Eid1704.101604 |
0.675 |
|
| 2011 |
Sakabe S, Ozawa M, Takano R, Iwastuki-Horimoto K, Kawaoka Y. Mutations in PA, NP, and HA of a pandemic (H1N1) 2009 influenza virus contribute to its adaptation to mice Virus Research. 158: 124-129. PMID 21458512 DOI: 10.1016/J.Virusres.2011.03.022 |
0.64 |
|
| 2011 |
Tomita Y, Noda T, Fujii K, Watanabe T, Morikawa Y, Kawaoka Y. The cellular factors Vps18 and Mon2 are required for efficient production of infectious HIV-1 particles Journal of Virology. 85: 5618-5627. PMID 21450827 DOI: 10.1128/Jvi.00846-10 |
0.306 |
|
| 2011 |
Shinya K, Makino A, Tanaka H, Hatta M, Watanabe T, Le MQ, Imai H, Kawaoka Y. Systemic dissemination of H5N1 influenza a viruses in ferrets and hamsters after direct intragastric inoculation Journal of Virology. 85: 4673-4678. PMID 21411541 DOI: 10.1128/Jvi.00148-11 |
0.611 |
|
| 2011 |
Shinya K, Makino A, Hatta M, Watanabe S, Kim JH, Hatta Y, Gao P, Ozawa M, Le QM, Kawaoka Y. Subclinical brain injury caused by H5N1 influenza virus infection. Journal of Virology. 85: 5202-7. PMID 21389133 DOI: 10.1128/Jvi.00239-11 |
0.579 |
|
| 2011 |
Shinya K, Okamura T, Sueta S, Kasai N, Tanaka M, Ginting TE, Makino A, Eisfeld AJ, Kawaoka Y. Toll-like receptor pre-stimulation protects mice against lethal infection with highly pathogenic influenza viruses. Virology Journal. 8: 97. PMID 21375734 DOI: 10.1186/1743-422X-8-97 |
0.668 |
|
| 2011 |
Sakabe S, Iwatsuki-Horimoto K, Takano R, Nidom CA, Le Mt, Nagamura-Inoue T, Horimoto T, Yamashita N, Kawaoka Y. Cytokine production by primary human macrophages infected with highly pathogenic H5N1 or pandemic H1N1 2009 influenza viruses. The Journal of General Virology. 92: 1428-34. PMID 21367984 DOI: 10.1099/Vir.0.030346-0 |
0.634 |
|
| 2011 |
Kiso M, Ozawa M, Le MT, Imai H, Takahashi K, Kakugawa S, Noda T, Horimoto T, Kawaoka Y. Effect of an asparagine-to-serine mutation at position 294 in neuraminidase on the pathogenicity of highly pathogenic H5N1 influenza A virus. Journal of Virology. 85: 4667-72. PMID 21367898 DOI: 10.1128/Jvi.00047-11 |
0.58 |
|
| 2011 |
Iwatsuki-Horimoto K, Horimoto T, Tamura D, Kiso M, Kawakami E, Hatakeyama S, Ebihara Y, Koibuchi T, Fujii T, Takahashi K, Shimojima M, Sakai-Tagawa Y, Ito M, Sakabe S, Iwasa A, ... ... Kawaoka Y, et al. Seroprevalence of pandemic 2009 (H1N1) influenza A virus among schoolchildren and their parents in Tokyo, Japan Clinical and Vaccine Immunology. 18: 860-866. PMID 21346056 DOI: 10.1128/Cvi.00428-10 |
0.603 |
|
| 2011 |
Ozawa M, Basnet S, Burley LM, Neumann G, Hatta M, Kawaoka Y. Impact of amino acid mutations in PB2, PB1-F2, and NS1 on the replication and pathogenicity of pandemic (H1N1) 2009 influenza viruses Journal of Virology. 85: 4596-4601. PMID 21325408 DOI: 10.1128/Jvi.00029-11 |
0.589 |
|
| 2011 |
Watanabe T, Kawaoka Y. Pathogenesis of the 1918 Pandemic Influenza Virus Plos Pathogens. 7. PMID 21298032 DOI: 10.1371/Journal.Ppat.1001218 |
0.568 |
|
| 2011 |
Hatta Y, Hatta M, Bilsel P, Neumann G, Kawaoka Y. An M2 cytoplasmic tail mutant as a live attenuated influenza vaccine against pandemic (H1N1) 2009 influenza virus. Vaccine. 29: 2308-2312. PMID 21272601 DOI: 10.1016/J.Vaccine.2011.01.023 |
0.649 |
|
| 2011 |
Tamura D, Sugaya N, Ozawa M, Takano R, Ichikawa M, Yamazaki M, Kawakami C, Shimizu H, Uehara R, Kiso M, Kawakami E, Mitamura K, Kawaoka Y. Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitors. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 52: 432-7. PMID 21248368 DOI: 10.1093/Cid/Ciq183 |
0.587 |
|
| 2011 |
Shtanko O, Watanabe S, Jasenosky LD, Watanabe T, Kawaoka Y. ALIX/AIP1 Is Required for NP Incorporation into Mopeia Virus Z-Induced Virus-Like Particles Journal of Virology. 85: 3631-3641. PMID 21248028 DOI: 10.1128/Jvi.01984-10 |
0.504 |
|
| 2011 |
Octaviani CP, Li C, Noda T, Kawaoka Y. Reassortment between seasonal and swine-origin H1N1 influenza viruses generates viruses with enhanced growth capability in cell culture. Virus Research. 156: 147-150. PMID 21195732 DOI: 10.1016/J.Virusres.2010.12.014 |
0.647 |
|
| 2011 |
Kawakami E, Watanabe T, Fujii K, Goto H, Watanabe S, Noda T, Kawaoka Y. Strand-specific real-time RT-PCR for distinguishing influenza vRNA, cRNA, and mRNA Journal of Virological Methods. 173: 1-6. PMID 21185869 DOI: 10.1016/J.Jviromet.2010.12.014 |
0.466 |
|
| 2011 |
Song J, Feng H, Xu J, Zhao D, Shi J, Li Y, Deng G, Jiang Y, Li X, Zhu P, Guan Y, Bu Z, Kawaoka Y, Chen H. The PA protein directly contributes to the virulence of H5N1 avian influenza viruses in domestic ducks. Journal of Virology. 85: 2180-8. PMID 21177821 DOI: 10.1128/Jvi.01975-10 |
0.632 |
|
| 2011 |
Watanabe T, Sakurai A, Kawaoka Y. [Identification of host factors involved in influenza virus replication]. Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme. 54: 920-5. PMID 21089518 |
0.569 |
|
| 2011 |
Shinya K, Yamada S, Kawaoka Y. [Receptor specificity of influenza viruses]. Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme. 53: 1520-4. PMID 21089359 |
0.497 |
|
| 2011 |
Safronetz D, Rockx B, Feldmann F, Belisle SE, Palermo RE, Brining D, Gardner D, Proll SC, Marzi A, Tsuda Y, Lacasse RA, Kercher L, York A, Korth MJ, Long D, ... ... Kawaoka Y, et al. Pandemic swine-origin H1N1 influenza A virus isolates show heterogeneous virulence in macaques. Journal of Virology. 85: 1214-23. PMID 21084481 DOI: 10.1128/Jvi.01848-10 |
0.665 |
|
| 2011 |
Shiozaki T, Iwai A, Kawaoka Y, Takada A, Kida H, Miyazaki T. Requirement for Siva-1 for replication of influenza A virus through apoptosis induction. The Journal of General Virology. 92: 315-25. PMID 21048035 DOI: 10.1099/Vir.0.028316-0 |
0.653 |
|
| 2011 |
Akarsu H, Iwatsuki-Horimoto K, Noda T, Kawakami E, Katsura H, Baudin F, Horimoto T, Kawaoka Y. Structure-based design of NS2 mutants for attenuated influenza A virus vaccines. Virus Research. 155: 240-8. PMID 20970464 DOI: 10.1016/J.Virusres.2010.10.014 |
0.55 |
|
| 2011 |
Hatakeyama S, Ozawa M, Kawaoka Y. In vitro selection of influenza B viruses with reduced sensitivity to neuraminidase inhibitors Clinical Microbiology and Infection. 17: 1332-1335. PMID 20636420 DOI: 10.1111/J.1469-0691.2010.03313.X |
0.517 |
|
| 2010 |
Takahashi T, Kurebayashi Y, Ikeya K, Mizuno T, Fukushima K, Kawamoto H, Kawaoka Y, Suzuki Y, Suzuki T. The low-pH stability discovered in neuraminidase of 1918 pandemic influenza A virus enhances virus replication. Plos One. 5. PMID 21151571 DOI: 10.1371/Journal.Pone.0015556 |
0.572 |
|
| 2010 |
Haraguchi H, Sudo S, Noda T, Momose F, Kawaoka Y, Morikawa Y. Intracellular localization of human immunodeficiency virus type 1 Gag and GagPol products and virus particle release: relationship with the Gag-to-GagPol ratio. Microbiology and Immunology. 54: 734-46. PMID 21091985 DOI: 10.1111/J.1348-0421.2010.00276.X |
0.429 |
|
| 2010 |
Kuhn JH, Becker S, Ebihara H, Geisbert TW, Johnson KM, Kawaoka Y, Lipkin WI, Negredo AI, Netesov SV, Nichol ST, Palacios G, Peters CJ, Tenorio A, Volchkov VE, Jahrling PB. Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Archives of Virology. 155: 2083-103. PMID 21046175 DOI: 10.1007/S00705-010-0814-X |
0.598 |
|
| 2010 |
Hatta Y, Hershberger K, Shinya K, Proll SC, Dubielzig RR, Hatta M, Katze MG, Kawaoka Y, Suresh M. Viral replication rate regulates clinical outcome and CD8 T cell responses during highly pathogenic H5N1 influenza virus infection in mice. Plos Pathogens. 6: e1001139. PMID 20949022 DOI: 10.1371/Journal.Ppat.1001139 |
0.612 |
|
| 2010 |
Arii J, Goto H, Suenaga T, Oyama M, Kozuka-Hata H, Imai T, Minowa A, Akashi H, Arase H, Kawaoka Y, Kawaguchi Y. Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1. Nature. 467: 859-62. PMID 20944748 DOI: 10.1038/Nature09420 |
0.443 |
|
| 2010 |
Nanbo A, Imai M, Watanabe S, Noda T, Takahashi K, Neumann G, Halfmann P, Kawaoka Y. Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. Plos Pathogens. 6. PMID 20886108 DOI: 10.1371/Journal.Ppat.1001121 |
0.44 |
|
| 2010 |
Nidom CA, Takano R, Yamada S, Sakai-Tagawa Y, Daulay S, Aswadi D, Suzuki T, Suzuki Y, Shinya K, Iwatsuki-Horimoto K, Muramoto Y, Kawaoka Y. Influenza A (H5N1) Viruses from Pigs, Indonesia Emerging Infectious Diseases. 16: 1515-1523. PMID 20875275 DOI: 10.3201/Eid1610.100508 |
0.682 |
|
| 2010 |
Kiso M, Shinya K, Shimojima M, Takano R, Takahashi K, Katsura H, Kakugawa S, Le MT, Yamashita M, Furuta Y, Ozawa M, Kawaoka Y. Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses. Plos Pathogens. 6: e1001079. PMID 20865125 DOI: 10.1371/Journal.Ppat.1001079 |
0.602 |
|
| 2010 |
Imai H, Shinya K, Takano R, Kiso M, Muramoto Y, Sakabe S, Murakami S, Ito M, Yamada S, Le MT, Nidom CA, Sakai-Tagawa Y, Takahashi K, Omori Y, Noda T, ... ... Kawaoka Y, et al. The HA and NS genes of human H5N1 influenza A virus contribute to high virulence in ferrets. Plos Pathogens. 6: e1001106. PMID 20862325 DOI: 10.1371/Journal.Ppat.1001106 |
0.676 |
|
| 2010 |
Noda T, Kawaoka Y. Structure of influenza virus ribonucleoprotein complexes and their packaging into virions. Reviews in Medical Virology. 20: 380-391. PMID 20853340 DOI: 10.1002/Rmv.666 |
0.492 |
|
| 2010 |
Sakabe S, Iwatsuki-Horimoto K, Horimoto T, Nidom CA, Le Mt, Takano R, Kubota-Koketsu R, Okuno Y, Ozawa M, Kawaoka Y. A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection. Antiviral Research. 88: 249-55. PMID 20849879 DOI: 10.1016/J.Antiviral.2010.09.007 |
0.649 |
|
| 2010 |
Horimoto T, Yamada S, Kawaoka Y. Virological characteristics of pandemic (H1N1) 2009 influenza virus Uirusu. 60: 3-8. PMID 20848859 DOI: 10.2222/Jsv.60.3 |
0.682 |
|
| 2010 |
Horimoto T, Yamada S, Kawaoka Y. [Transmissibility and pathogenicity of influenza viruses]. Nihon Rinsho. Japanese Journal of Clinical Medicine. 68: 1616-23. PMID 20845737 |
0.601 |
|
| 2010 |
Noda T, Kawaoka Y. [Mechanisms of influenza virus replication]. Nihon Rinsho. Japanese Journal of Clinical Medicine. 68: 1611-5. PMID 20845736 |
0.483 |
|
| 2010 |
Noda T, Kawaoka Y. [Genetic and molecular characteristics of the 2009 H1N1 pandemic influenza A virus]. Nihon Rinsho. Japanese Journal of Clinical Medicine. 68: 1590-3. PMID 20845732 |
0.563 |
|
| 2010 |
Yamada S, Hatta M, Staker BL, Watanabe S, Imai M, Shinya K, Sakai-Tagawa Y, Ito M, Ozawa M, Watanabe T, Sakabe S, Li C, Kim JH, Myler PJ, Phan I, ... ... Kawaoka Y, et al. Biological and structural characterization of a host-adapting amino acid in influenza virus. Plos Pathogens. 6: e1001034. PMID 20700447 DOI: 10.1371/Journal.Ppat.1001034 |
0.62 |
|
| 2010 |
Iwai A, Shiozaki T, Kawai T, Akira S, Kawaoka Y, Takada A, Kida H, Miyazaki T. Influenza A virus polymerase inhibits type I interferon induction by binding to interferon beta promoter stimulator 1. The Journal of Biological Chemistry. 285: 32064-74. PMID 20699220 DOI: 10.1074/Jbc.M110.112458 |
0.616 |
|
| 2010 |
Octaviani CP, Ozawa M, Yamada S, Goto H, Kawaoka Y. High level of genetic compatibility between swine-origin H1N1 and highly pathogenic avian H5N1 influenza viruses. Journal of Virology. 84: 10918-10922. PMID 20686037 DOI: 10.1128/Jvi.01140-10 |
0.668 |
|
| 2010 |
Grandea AG, Olsen OA, Cox TC, Renshaw M, Hammond PW, Chan-Hui PY, Mitcham JL, Cieplak W, Stewart SM, Grantham ML, Pekosz A, Kiso M, Shinya K, Hatta M, Kawaoka Y, et al. Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses. Proceedings of the National Academy of Sciences of the United States of America. 107: 12658-63. PMID 20615945 DOI: 10.1073/Pnas.0911806107 |
0.607 |
|
| 2010 |
Le QM, Ito M, Muramoto Y, Hoang PV, Vuong CD, Sakai-Tagawa Y, Kiso M, Ozawa M, Takano R, Kawaoka Y. Pathogenicity of highly pathogenic avian H5N1 influenza A viruses isolated from humans between 2003 and 2008 in northern Vietnam. The Journal of General Virology. 91: 2485-90. PMID 20592108 DOI: 10.1099/Vir.0.021659-0 |
0.607 |
|
| 2010 |
Chen Y, Zhong G, Wang G, Deng G, Li Y, Shi J, Zhang Z, Guan Y, Jiang Y, Bu Z, Kawaoka Y, Chen H. Dogs are highly susceptible to H5N1 avian influenza virus. Virology. 405: 15-9. PMID 20580396 DOI: 10.1016/J.Virol.2010.05.024 |
0.617 |
|
| 2010 |
Sakai-Tagawa Y, Ozawa M, Tamura D, Le Mt, Nidom CA, Sugaya N, Kawaoka Y. Sensitivity of influenza rapid diagnostic tests to H5N1 and 2009 pandemic H1N1 viruses. Journal of Clinical Microbiology. 48: 2872-7. PMID 20554831 DOI: 10.1128/Jcm.00439-10 |
0.659 |
|
| 2010 |
Watanabe T, Watanabe S, Kawaoka Y. Cellular Networks Involved in the Influenza Virus Life Cycle Cell Host & Microbe. 7: 427-439. PMID 20542247 DOI: 10.1016/J.Chom.2010.05.008 |
0.642 |
|
| 2010 |
Monteerarat Y, Sakabe S, Ngamurulert S, Srichatraphimuk S, Jiamtom W, Chaichuen K, Thitithanyanont A, Permpikul P, Songserm T, Puthavathana P, Nidom CA, Mai LQ, Iwatsuki-Horimoto K, Kawaoka Y, Auewarakul P. Induction of TNF-α in human macrophages by avian and human influenza viruses Archives of Virology. 155: 1273-1279. PMID 20532927 DOI: 10.1007/S00705-010-0716-Y |
0.522 |
|
| 2010 |
Tamura D, Fujino M, Ozawa M, Iwatsuki-Horimoto K, Goto H, Sakai-Tagawa Y, Horimoto T, Nirasawa M, Kawaoka Y. Significance of seasonal influenza viruses in the stool of pediatric patients. Pediatric Infectious Disease Journal. 29: 578-579. PMID 20508482 DOI: 10.1097/Inf.0B013E3181Dab225 |
0.593 |
|
| 2010 |
Jasenosky LD, Neumann G, Kawaoka Y. Minigenome-Based Reporter System Suitable for High-Throughput Screening of Compounds Able To Inhibit Ebolavirus Replication and/or Transcription Antimicrobial Agents and Chemotherapy. 54: 3007-3010. PMID 20421407 DOI: 10.1128/Aac.00138-10 |
0.307 |
|
| 2010 |
Matsuno K, Kishida N, Usami K, Igarashi M, Yoshida R, Nakayama E, Shimojima M, Feldmann H, Irimura T, Kawaoka Y, Takada A. Different Potential of C-Type Lectin-Mediated Entry between Marburg Virus Strains Journal of Virology. 84: 5140-5147. PMID 20219911 DOI: 10.1128/Jvi.02021-09 |
0.437 |
|
| 2010 |
Shtanko O, Imai M, Goto H, Lukashevich IS, Neumann G, Watanabe T, Kawaoka Y. A role for the C terminus of Mopeia virus nucleoprotein in its incorporation into Z protein-induced virus-like particles. Journal of Virology. 84: 5415-22. PMID 20200234 DOI: 10.1128/Jvi.02417-09 |
0.481 |
|
| 2010 |
Kiso M, Kubo S, Ozawa M, Le QM, Nidom CA, Yamashita M, Kawaoka Y. Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses. Plos Pathogens. 6: e1000786. PMID 20195462 DOI: 10.1371/Journal.Ppat.1000786 |
0.633 |
|
| 2010 |
Li C, Hatta M, Nidom CA, Muramoto Y, Watanabe S, Neumann G, Kawaoka Y. Reassortment between avian H5N1 and human H3N2 influenza viruses creates hybrid viruses with substantial virulence Proceedings of the National Academy of Sciences of the United States of America. 107: 4687-4692. PMID 20176961 DOI: 10.1073/Pnas.0912807107 |
0.689 |
|
| 2010 |
Noda T, Hagiwara K, Sagara H, Kawaoka Y. Characterization of the Ebola virus nucleoprotein-RNA complex. Journal of General Virology. 91: 1478-1483. PMID 20164259 DOI: 10.1099/Vir.0.019794-0 |
0.413 |
|
| 2010 |
Shinya K, Makino A, Hatta M, Watanabe S, Kim JH, Kawaoka Y. A mutation in H5 haemagglutinin that conferred human receptor recognition is not maintained stably during duck passage. The Journal of General Virology. 91: 1461-3. PMID 20130132 DOI: 10.1099/Vir.0.018572-0 |
0.505 |
|
| 2010 |
Kiso M, Takahashi K, Sakai-Tagawa Y, Shinya K, Sakabe S, Le QM, Ozawa M, Furuta Y, Kawaoka Y. T-705 (favipiravir) activity against lethal H5N1 influenza A viruses. Proceedings of the National Academy of Sciences of the United States of America. 107: 882-887. PMID 20080770 DOI: 10.1073/Pnas.0909603107 |
0.651 |
|
| 2010 |
Shinya K, Makino A, Kawaoka Y. Emerging and Reemerging Influenza Virus Infections Veterinary Pathology. 47: 53-57. PMID 20080485 DOI: 10.1177/0300985809354464 |
0.667 |
|
| 2010 |
Kim JH, Hatta M, Watanabe S, Neumann G, Watanabe T, Kawaoka Y. Role of host-specific amino acids in the pathogenicity of avian H5N1 influenza viruses in mice. The Journal of General Virology. 91: 1284-9. PMID 20016035 DOI: 10.1099/Vir.0.018143-0 |
0.628 |
|
| 2010 |
Neumann G, Chen H, Gao GF, Shu Y, Kawaoka Y. H5N1 influenza viruses: outbreaks and biological properties Cell Research. 20: 51-61. PMID 19884910 DOI: 10.1038/Cr.2009.124 |
0.675 |
|
| 2010 |
Horimoto T, Kawaoka Y. Pandemic Influenza~!2010-01-17~!2010-04-05~!2010-08-27~! The Open Antimicrobial Agents Journal. 2: 9-14. DOI: 10.2174/1876518101002020009 |
0.612 |
|
| 2009 |
Gao Y, Zhang Y, Shinya K, Deng G, Jiang Y, Li Z, Guan Y, Tian G, Li Y, Shi J, Liu L, Zeng X, Bu Z, Xia X, Kawaoka Y, et al. Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host. Plos Pathogens. 5: e1000709. PMID 20041223 DOI: 10.1371/Journal.Ppat.1000709 |
0.639 |
|
| 2009 |
Cillóniz C, Shinya K, Peng X, Korth MJ, Proll SC, Aicher LD, Carter VS, Chang JH, Kobasa D, Feldmann F, Strong JE, Feldmann H, Kawaoka Y, Katze MG. Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. Plos Pathogens. 5: e1000604. PMID 19798428 DOI: 10.1371/Journal.Ppat.1000604 |
0.626 |
|
| 2009 |
Shinya K, Makino A, Ozawa M, Kim JH, Sakai-Tagawa Y, Ito M, Le QM, Kawaoka Y. Ostrich involvement in the selection of H5N1 influenza virus possessing mammalian-type amino acids in the PB2 protein. Journal of Virology. 83: 13015-8. PMID 19793811 DOI: 10.1128/Jvi.01714-09 |
0.649 |
|
| 2009 |
Horimoto T, Kawaoka Y. Designing vaccines for pandemic influenza. Current Topics in Microbiology and Immunology. 333: 165-176. PMID 19768405 DOI: 10.1007/978-3-540-92165-3_8 |
0.537 |
|
| 2009 |
Kashima Y, Ikeda M, Itoh Y, Sakoda Y, Nagata T, Miyake T, Soda K, Ozaki H, Nakayama M, Shibuya H, Okamatsu M, Ishigaki H, Ishida H, Sawai T, Kawaoka Y, et al. Intranasal administration of a live non-pathogenic avian H5N1 influenza virus from a virus library confers protective immunity against H5N1 highly pathogenic avian influenza virus infection in mice: comparison of formulations and administration routes of vaccines. Vaccine. 27: 7402-7408. PMID 19747993 DOI: 10.1016/J.Vaccine.2009.08.089 |
0.609 |
|
| 2009 |
Takahashi T, Hashimoto A, Maruyama M, Ishida H, Kiso M, Kawaoka Y, Suzuki Y, Suzuki T. Identification of amino acid residues of influenza A virus H3 HA contributing to the recognition of molecular species of sialic acid Febs Letters. 583: 3171-3174. PMID 19720062 DOI: 10.1016/J.Febslet.2009.08.037 |
0.492 |
|
| 2009 |
Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, Muramoto Y, Tamura D, Sakai-Tagawa Y, Noda T, Sakabe S, Imai M, Hatta Y, Watanabe S, Li C, ... ... Kawaoka Y, et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature. 460: 1021-5. PMID 19672242 DOI: 10.1038/Nature08260 |
0.622 |
|
| 2009 |
Zhou B, Donnelly ME, Scholes DT, George KS, Hatta M, Kawaoka Y, Wentworth DE. Single-Reaction Genomic Amplification Accelerates Sequencing and Vaccine Production for Classical and Swine Origin Human Influenza A Viruses Journal of Virology. 83: 10309-10313. PMID 19605485 DOI: 10.1128/Jvi.01109-09 |
0.575 |
|
| 2009 |
Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature. 459: 931-939. PMID 19525932 DOI: 10.1038/Nature08157 |
0.65 |
|
| 2009 |
Donis RO, Smith G, Brown IH, Capua I, Cattoli G, Chen H, Cox N, Davis CT, Fouchier RAM, Garten R, Guan Y, Hay A, Kawaoka Y, Mackenzie J, McCauley J, et al. Continuing progress towards a unified nomenclature for the highly pathogenic H5N1 avian influenza viruses: Divergence of clade 2·2 viruses Influenza and Other Respiratory Viruses. 3: 59-62. PMID 19496842 DOI: 10.1111/J.1750-2659.2009.00078.X |
0.562 |
|
| 2009 |
Takano R, Nidom CA, Kiso M, Muramoto Y, Yamada S, Sakai-Tagawa Y, Macken C, Kawaoka Y. Phylogenetic characterization of H5N1 avian influenza viruses isolated in Indonesia from 2003–2007 Virology. 390: 13-21. PMID 19464724 DOI: 10.1016/J.Virol.2009.04.024 |
0.667 |
|
| 2009 |
Makino A, Kawaoka Y. Generation of Vero Cells Expressing Ebola Virus Glycoprotein Journal of Veterinary Medical Science. 71: 505-507. PMID 19420858 DOI: 10.1292/Jvms.71.505 |
0.455 |
|
| 2009 |
Fan S, Gao Y, Shinya K, Li CK, Li Y, Shi J, Jiang Y, Suo Y, Tong T, Zhong G, Song J, Zhang Y, Tian G, Guan Y, Xu XN, ... ... Kawaoka Y, et al. Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates. Plos Pathogens. 5: e1000409. PMID 19412338 DOI: 10.1371/Journal.Ppat.1000409 |
0.62 |
|
| 2009 |
Kakugawa S, Shimojima M, Neumann G, Goto H, Kawaoka Y. RuvB-Like Protein 2 Is a Suppressor of Influenza A Virus Polymerases Journal of Virology. 83: 6429-6434. PMID 19369355 DOI: 10.1128/Jvi.00293-09 |
0.648 |
|
| 2009 |
Watanabe S, Watanabe T, Kawaoka Y. Influenza A Virus Lacking M2 Protein as a Live Attenuated Vaccine Journal of Virology. 83: 5947-5950. PMID 19321619 DOI: 10.1128/Jvi.00450-09 |
0.605 |
|
| 2009 |
Fujii K, Ozawa M, Iwatsuki-Horimoto K, Horimoto T, Kawaoka Y. Incorporation of influenza A virus genome segments does not absolutely require wild-type sequences. Journal of General Virology. 90: 1734-1740. PMID 19297607 DOI: 10.1099/Vir.0.010355-0 |
0.54 |
|
| 2009 |
Takano R, Nidom CA, Kiso M, Muramoto Y, Yamada S, Shinya K, Sakai-Tagawa Y, Kawaoka Y. A comparison of the pathogenicity of avian and swine H5N1 influenza viruses in Indonesia. Archives of Virology. 154: 677-681. PMID 19288052 DOI: 10.1007/S00705-009-0353-5 |
0.655 |
|
| 2009 |
Hatta M, Kohlmeier CK, Hatta Y, Ozawa M, Kawaoka Y. Region required for protein expression from the stop-start pentanucleotide in the M gene of influenza B virus. Journal of Virology. 83: 5939-5942. PMID 19279094 DOI: 10.1128/Jvi.00180-09 |
0.408 |
|
| 2009 |
Le QM, Sakai-Tagawa Y, Ozawa M, Ito M, Kawaoka Y. Selection of H5N1 Influenza Virus PB2 during Replication in Humans Journal of Virology. 83: 5278-5281. PMID 19264775 DOI: 10.1128/Jvi.00063-09 |
0.641 |
|
| 2009 |
Makino A, Horimoto T, Kawaoka Y. Binding properties of GP1 protein of Borna disease virus. Journal of Veterinary Medical Science. 71: 243-246. PMID 19262042 DOI: 10.1292/Jvms.71.243 |
0.401 |
|
| 2009 |
Tamura D, Mitamura K, Yamazaki M, Fujino M, Nirasawa M, Kimura K, Kiso M, Shimizu H, Kawakami C, Hiroi S, Takahashi K, Hata M, Minagawa H, Kimura Y, Kaneda S, ... ... Kawaoka Y, et al. Oseltamivir-resistant influenza a viruses circulating in Japan. Journal of Clinical Microbiology. 47: 1424-7. PMID 19261802 DOI: 10.1128/Jcm.02396-08 |
0.57 |
|
| 2009 |
Li Z, Watanabe T, Hatta M, Watanabe S, Nanbo A, Ozawa M, Kakugawa S, Shimojima M, Yamada S, Neumann G, Kawaoka Y. Mutational analysis of conserved amino acids in the influenza A virus nucleoprotein. Journal of Virology. 83: 4153-62. PMID 19225007 DOI: 10.1128/Jvi.02642-08 |
0.482 |
|
| 2009 |
Halfmann P, Ebihara H, Marzi A, Hatta Y, Watanabe S, Suresh M, Neumann G, Feldmann H, Kawaoka Y. Replication-deficient ebolavirus as a vaccine candidate. Journal of Virology. 83: 3810-3815. PMID 19211761 DOI: 10.1128/Jvi.00074-09 |
0.536 |
|
| 2009 |
Marsolais D, Hahm B, Walsh KB, Edelmann KH, McGavern D, Hatta Y, Kawaoka Y, Rosen H, Oldstone MB. A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection. Proceedings of the National Academy of Sciences of the United States of America. 106: 1560-5. PMID 19164548 DOI: 10.1073/Pnas.0812689106 |
0.523 |
|
| 2009 |
Ozawa M, Maeda J, Iwatsuki-Horimoto K, Watanabe S, Goto H, Horimoto T, Kawaoka Y. Nucleotide Sequence Requirements at the 5′ End of the Influenza A Virus M RNA Segment for Efficient Virus Replication Journal of Virology. 83: 3384-3388. PMID 19158245 DOI: 10.1128/Jvi.02513-08 |
0.469 |
|
| 2009 |
Kakugawa S, Shimojima M, Goto H, Horimoto T, Oshimori N, Neumann G, Yamamoto T, Kawaoka Y. Mitogen-Activated Protein Kinase-Activated Kinase RSK2 Plays a Role in Innate Immune Responses to Influenza Virus Infection Journal of Virology. 83: 2510-2517. PMID 19129453 DOI: 10.1128/Jvi.02416-08 |
0.525 |
|
| 2009 |
Fan S, Deng G, Song J, Tian G, Suo Y, Jiang Y, Guan Y, Bu Z, Kawaoka Y, Chen H. Two amino acid residues in the matrix protein M1 contribute to the virulence difference of H5N1 avian influenza viruses in mice. Virology. 384: 28-32. PMID 19117585 DOI: 10.1016/J.Virol.2008.11.044 |
0.591 |
|
| 2009 |
Watanabe T, Watanabe S, Shinya K, Kim JH, Hatta M, Kawaoka Y. Viral RNA polymerase complex promotes optimal growth of 1918 virus in the lower respiratory tract of ferrets. Proceedings of the National Academy of Sciences of the United States of America. 106: 588-92. PMID 19114663 DOI: 10.1073/Pnas.0806959106 |
0.665 |
|
| 2009 |
Sakuma T, Noda T, Urata S, Kawaoka Y, Yasuda J. Inhibition of Lassa and Marburg Virus Production by Tetherin Journal of Virology. 83: 2382-2385. PMID 19091864 DOI: 10.1128/Jvi.01607-08 |
0.581 |
|
| 2009 |
Murakami S, Horimoto T, Kawaoka Y. Construction and application of the recombinant influenza viruses Drug Delivery System. 24: 616-626. DOI: 10.2745/Dds.24.616 |
0.624 |
|
| 2008 |
Wit Ed, Kawaoka Y, Jong MDd, Fouchier RAM. Pathogenicity of highly pathogenic avian influenza virus in mammals Vaccine. 26. PMID 19230161 DOI: 10.1016/J.Vaccine.2008.07.072 |
0.668 |
|
| 2008 |
Horimoto T, Murakami S, Kawaoka Y. [Influenza vaccine]. Nihon Rinsho. Japanese Journal of Clinical Medicine. 66: 2013-8. PMID 18939506 |
0.361 |
|
| 2008 |
Li C, Hatta M, Watanabe S, Neumann G, Kawaoka Y. Compatibility among Polymerase Subunit Proteins Is a Restricting Factor in Reassortment between Equine H7N7 and Human H3N2 Influenza Viruses Journal of Virology. 82: 11880-11888. PMID 18815312 DOI: 10.1128/Jvi.01445-08 |
0.632 |
|
| 2008 |
Murakami S, Iwasa A, Iwatsuki-Horimoto K, Ito M, Kiso M, Kida H, Takada A, Nidom CA, Mai LQ, Yamada S, Imai H, Sakai-Tagawa Y, Kawaoka Y, Horimoto T. Cross-clade protective immunity of H5N1 influenza vaccines in a mouse model Vaccine. 26: 6398-6404. PMID 18804131 DOI: 10.1016/J.Vaccine.2008.08.053 |
0.466 |
|
| 2008 |
Jia B, Shi J, Li Y, Shinya K, Muramoto Y, Zeng X, Tian G, Kawaoka Y, Chen H. Pathogenicity of Chinese H5N1 highly pathogenic avian influenza viruses in pigeons. Archives of Virology. 153: 1821-6. PMID 18779923 DOI: 10.1007/S00705-008-0193-8 |
0.658 |
|
| 2008 |
Murakami S, Horimoto T, Le QM, Nidom CA, Chen H, Muramoto Y, Yamada S, Iwasa A, Iwatsuki-Horimoto K, Shimojima M, Iwata A, Kawaoka Y. Growth determinants for H5N1 influenza vaccine seed viruses in MDCK cells Journal of Virology. 82: 10502-10509. PMID 18768983 DOI: 10.1128/Jvi.00970-08 |
0.621 |
|
| 2008 |
Hao L, Sakurai A, Watanabe T, Sorensen E, Nidom CA, Newton MA, Ahlquist P, Kawaoka Y. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature. 454: 890-3. PMID 18615016 DOI: 10.1038/Nature07151 |
0.666 |
|
| Show low-probability matches. |